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Malaria is one of the most prevalent epidemic diseases in the world, particularly in the subtropical 
and tropical regions. The control of this disease is hindered by spreading drug resistance of the 
malaria parasite, Plasmodium species which necessitates the search for new therapeutic targets 
Phagocytosis of infected red blood cells represents the first line of defence against the parasite. 
Understanding the phagocytic process of malaria-infected erythrocytes and the subsequent 
cascade of host response are important in the development of new strategies for treating malaria. 
In this study, we focused on phosphatidylserine (PS) and its possible role in malaria pathogenesis 
through phagocytosis.  
PS exposure in cells is a hallmark feature of programmed cell death and parasite-induced PS 
exposure in both host cells and parasites themselves have been shown in different parasites 
(Leishmania, Toxoplasma gondii, Cryptosporidium parvum). Such apoptotic mimicry has been 
speculated to aid in parasite perpetuation and immune evasion as PS exposure induces phagocytic 
recognition and clearance in an anti-inflammatory manner. We have found that Plasmodium 
falciparum induces PS exposure in both infected and uninfected erythrocytes through a released 
factor. While the identity of this factor is still unknown, experiments have shown that it is 
particulate and its activity can be augmented by heat.  
In order to investigate the relationship between PS exposure in erythrocytes and phagocytosis, a 
new, sensitive method to assay for phagocytosis using flow cytometry was established.  
Dihydroethidine was used to label parasite DNA and CellTrace
TM
 Violet labelled the erythrocyte 
cytoplasm, allowing different populations and parasite stages within blood cultures to be analysed 
easily. We demonstrated that both infected and uninfected erythrocytes in P. falciparum cultures 
were phagocytosed by THP-1 monocytes and macrophages. In addition, the uptake of schizont-
infected erythrocytes was higher than that of ring-infected erythrocytes. Furthermore, to 
viii 
 
investigate the role of PS exposure in erythrophagocytosis, unlabelled Annexin V (a PS-binding 
protein) was used to inhibit PS-mediated phagocytosis. While the addition of Annexin V did not 
inhibit phagocytosis, an increase in IL-6 production and a decrease in IL-10 production by THP-1 
differentiated macrophages were observed. This may indicate an increase in pro-inflammatory 
signals through the blocking of PS.  
In conclusion, the role of PS in the phagocytosis of P. falciparum erythrocyte cultures and the 
subsequent cytokine production still remains unclear; however, the presence of apoptotic mimicry 
in P. falciparum cannot be ruled out. Further investigations involving various phagocytic 
inhibitors and the measurement of other different cytokines are required to elucidate the role of 
PS. This is important in understanding parasite pathogenesis and may help facilitate the discovery 
of novel drug targets.  
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1.1 Malaria: A Global Burden 
1.1.1 Malaria distribution and its strain on the economy 
Malaria is one of the most prevalent diseases in the world, particularly in the subtropical and 
tropical regions, with 106 endemic countries. World Health Organisation (WHO) estimated 
approximately 225 million clinical cases and 781,000 deaths in the year of 2009 alone (World 
Health Organization, 2010); however, these numbers are thought to be underestimates due to 
WHO’s reliance on passive reporting (Snow et al., 2005). Figure 1.1 shows the global 
distribution of people infected with Plasmodium falciparum malaria in 2007. 
 
 
Figure 1.1 The spatial distribution and intensity of Plasmodium falciparum malaria 
endemicity in the world (Hay et al., 2009) 
 
 
Often known as the disease of the poor, many studies have shown a correlation between 
malaria and poverty (Gallup and Sachs, 2001; Teklehaimanot and Paola Mejia, 2008; Yusuf 
et al., 2010). Malaria causes both tangible (reduced income due to treatment and prevention, 
loss in productivity and increased mortality) and intangible costs (reduction in tourism and 
foreign investments) to the community (Breman et al., 2004; Kiszewski and Teklehaimanot, 
2004). Estimates have found that annual economic growth rates of countries with malaria 
were 1.3% lower than countries without malaria (Sachs and Malaney, 2002; Chuma et al., 




1.1.2 Fight against malaria 
A program “Roll Back Malaria” was started in 1998 with the goal to halve malaria deaths by 
2010 and again by 2015 with the number of preventable deaths near zero by using four major 
tools: 1) insecticide-treated bednets, 2) effective detection and treatment with artemisinin 
combination therapy, 3) preventive treatment during pregnancy and 4) the general use of 
insecticides indoors for killing mosquito vectors (Yamey, 2004; Johansson et al., 2010). Some 
improvement was seen, evidenced by the drop in the estimated number of malaria cases and 
malaria deaths, from 233 million in 2000 to 225 million in 2009 and from 985 000 in 2000 to 
781 000 in 2009 respectively (World Health Organization, 2010). However, the lack of 
sufficient funds, changing climates, deforestation, urbanisation (with dam building, irrigation 
channels etc) and emerging drug resistance are set to increase the malaria burden again 
(Martens et al., 1995; Lindsay and Birley, 1996; Sachs and Malaney, 2002; Narasimhan and 
Attaran, 2003; Pattanayak et al., 2006; Reiter, 2008). 
 
Without an effective vaccine available and signs of resistance to the frontline drug, 
artemisinin (Noedl et al., 2008; Dondorp et al., 2009), discovering novel drug targets is 
imperative in the fight against malaria. To do this, a better understanding of the molecular 
mechanisms of host and parasite interactions is necessary. 
 
1.2 Malaria: The Disease 
Malaria is an infectious disease caused by obligate intracellular Apicomplexa parasitic 
protozoa that are members of the genus Plasmodium and it is transmitted by female 
Anopheles mosquitoes in humans. Four species, namely Plasmodium falciparum, Plasmodium 
vivax, Plasmodium ovale and Plasmodium malariae, are commonly known to infect humans. 
More recently, reports of Plasmodium knowlesi (natural parasites of long-tailed macaque 
monkeys) infecting humans particularly in the Southeast Asia have emerged, suggesting a 
fifth species involved in the spread of malaria (Singh et al., 2004; Cox-Singh et al., 2008). Of 
these, Plasmodium falciparum, which is the focus of this study, is the most pathogenic, 
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resulting in the most severe clinical symptoms and the majority of recorded deaths (Wellems 
et al., 2009).  
 
Figure 1.2 The life cycle of Plasmodium falciparum  
Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews Genetics, (Su et al., 
2007) Copyright © 2007 
 
The malaria life cycle (Figure 1.2) begins when mosquitoes ingest the parasite, in the form of 
gametocytes – sexual forms of the malaria parasite – while feeding on an infected human. The 
male and female gametes fuse in the mosquito gut to form a zygote. The zygote undergoes 
meiosis to eventually form an ookinete which migrates through the mosquito midgut 
epithelium. It then begins the oocyst stage where multiple sporozoites are formed. 
Sporozoites migrate to the mosquito salivary glands and are injected into the dermis of the 
next human host when the mosquito takes another meal (Baton and Ranford-Cartwright, 
2005).  
 
These sporozoites travel to the liver in the human host and invade hepatocytes where they 
form thousands of merozoites, each capable of invading an erythrocyte upon release. This 
initiates the erythrocytic phase of the infection where malaria pathology manifests. The 
invading merozoite binds to the erythrocyte via the apical end and causes the erythrocyte 
membrane to invaginate, forming a vacuole around it (parasitophorous vacuole, PV; Haldar 
and Mohandas, 2007). This begins the ring stage of the developmental cycle, which enlarges 
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and grows into the trophozoite stage and finally, the schizont stage. During the early ring 
stage, the host erythrocyte remains largely unchanged and as it develops into the trophozoite 
stage, more and more parasite molecules are synthesized. These modify the erythrocyte to 
increase permeability and cause cytoadherence. At the schizont stage, each parasite multiplies 
to form about 4-16 merozoites which are released into the circulation (after lysis of the 
erythrocyte) and invade other erythrocytes, repeating the erythrocytic cycle again. In P. 
falciparum, each erythrocytic cycle lasts about 48 hours (Bannister and Mitchell, 2003). 
 
Some merozoites, however, do not develop into schizonts. Rather, they form crescent-shaped 
gametocytes which are taken up by mosquitoes, thus completing the transmission cycle. The 
ratio of merozoites developing into either gametocytes or asexual blood stage parasites was 
estimated to be 1:156 on average; with detectable levels of gametocytes appearing in the 
peripheral blood only after approximately 7 days (Eichner et al., 2001; Talman et al., 2004).  
 
1.3 Pathogenesis in Falciparum Malaria 
1.3.1 Signs and symptoms 
The incubation time from the injection of sporozoites to the development of clinical 
symptoms can be as quick as 6 days but this may be delayed, depending on factors such as 
immunity due to previous exposures (Trampuz et al., 2003). Symptoms presented also vary 
widely between people.  
 
The sudden onset of fever and chills with a tertian (48 hours) cycle is a well characterised 
symptom, although this pattern tends to be irregular in falciparum malaria and some semi-
immune persons may even remain afebrile at low parasitemias (Grobusch and Kremsner, 
2005). Other general symptoms include headaches, dizziness, fatigue, malaise, muscle and 
joint pains, abdominal pains, nausea, vomiting and diarrhoea (Trampuz et al., 2003; Grobusch 
and Kremsner, 2005). In cases of severe disease, individuals may develop hyperparasitemia, 
severe anaemia, cerebral complications, metabolic acidosis, hypoglycaemia and other organ 
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complications/failure (Trampuz et al., 2003; Mackintosh et al., 2004; Idro et al., 2005; 
Schofield and Grau, 2005). Disease pathogenesis is thought to be a combination of both 
parasite-induced factors and the host immune response.  
 
1.3.2 Cytoadherence, sequestration and antigenic variation 
As the parasites mature, they express proteins such as P. falciparum erythrocyte membrane 
protein 1 (PfEMP1), a family of polymorphic proteins, on the surface of erythrocytes. These 
proteins, and hence the erythrocytes, are able to bind to receptors that can be found on the 
surface of vascular endothelial cells (cytoadherence). Examples of such receptors are 
intercellular adhesion molecule 1 (ICAM1), CD36, thrombospondin and endothelial cell 
selectin (Baruch et al., 1996; Schofield and Grau, 2005). Bound parasitised erythrocytes are 
sequestrated in the capillaries deep within various organs and in doing so, they avoid splenic 
destruction – a major way through which parasites are cleared from the body. Sequestration is 
enhanced as the parasitised erythrocytes bind to each other (autoagglutination), other 
uninfected erythrocytes (rosetting) and platelets (platelet-mediated clumping; Idro et al., 
2005). Sequestered erythrocytes may occlude capillaries, blocking oxygen transport which 
results in ischemia and subsequent organ failure. While the expression of PfEMP1 on the 
erythrocyte surface aids in cytoadherence, it is also recognised by protective antibodies (Bull 
et al., 1998; Nielsen et al., 2002). Hence, to avoid immune detection, the parasites express 
variant surface antigens and in vitro, this has been demonstrated to occur at a rate of 2% per 
parasite generation in the absence of immune pressure (Roberts et al., 1992). 
 
1.3.3 Effects of the host immune response 
During parasite intra-erythrocytic development, a variety of parasite molecules such as 
glycosylphosphatidylinositol (GPI), parasite DNA and RNA, lysyl-tRNA synthetase and 
haemozoin are produced. These are released into the plasma during erythrocyte lysis which 
stimulate the production of pro-inflammatory mediators such as tumour necrosis factor alpha 
(TNF ), interleukin 6 (IL-6), interleukin 1 (IL-1) and reactive oxygen species (Schofield et 
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al., 1993; Day et al., 1999; Naik et al., 2000; Lyke et al., 2004; Dostert et al., 2009). The 
overexpression of pro-inflammatory mediators is thought to be associated with much of the 
malaria pathology, including malarial sepsis shock-like syndrome (Clark et al., 1981; 
Maitland and Newton, 2005; Schofield and Grau, 2005). 
 
1.3.4 Increased erythrocyte clearance and decreased erythropoiesis 
Anaemia is a common outcome of malaria and studies have found that the severity of anaemia 
is not correlated to blood parasitemia; hence, the loss of red cells cannot be due solely to 
schizont rupture (Dondorp et al., 1999). Much of the anaemia in malarial patients is attributed 
to a combination of increased clearance of both infected and uninfected erythrocytes and 
decreased erythropoiesis (Haldar and Mohandas, 2009; Perkins et al., 2011).  
 
During the malarial infection, both infected and uninfected erythrocytes experience reduced 
deformability (Dondorp et al., 1999), increased apoptosis levels (Totino et al., 2010) and 
increased immunogenicity due to absorption of shed parasite antigens and immune factors to 
normal erythrocyte membrane (Waitumbi et al., 2000; Sterkers et al., 2007). This could result 
in increased clearance. Reduced erythropoietin production and suppression of erythropoiesis 
due to pro-inflammatory mediators could also contribute to anaemia (Hassan et al., 1997; 
Chang and Stevenson, 2004; McDevitt et al., 2004; Casals-Pascual et al., 2006; Were et al., 
2006). 
 
1.4 Parasite- Host Interactions – Apoptotic Mimicry? 
1.4.1 Programmed cell death (PCD) 
Programmed cell death (PCD) is the death of a cell in a genetically-regulated manner, in 
response to intracellular or extracellular stimuli. It involves the systematic dismantling of 
cells without inducing an inflammatory response and this is in contrast with accidental 
necrosis which results in the uncontrolled release of cellular contexts and therefore, an 
inflammatory response (Fink and Cookson, 2005). Common types of PCD are apoptosis and 
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autophagy, although there are other less common ones such as cornification, anoikis, 
paraptosis etc (Kroemer et al., 2009). 
 
Typical morphological markers of PCD, in particular apoptosis, include loss of mitochondrial 
membrane potential, chromatin condensation, DNA fragmentation, cell shrinkage, membrane 
blebbing and the loss of membrane phospholipid asymmetry (Fink and Cookson, 2005; 
Kroemer et al., 2009). Even mature erythrocytes that possess no organelles undergo a form of 
apoptosis, with features mainly concerning the cell membrane (Bratosin et al., 2001). This 
was termed “eryptosis” (Lang et al., 2005; Föller et al., 2008).  
 
1.4.2 Phosphatidylserine distribution and its externalisation in the cell membrane 
In healthy cells, phospholipids are distributed asymmetrically across the membrane lipid 
bilayer. Choline-containing phospholipids, phosphatidylcholine (PC) and sphingomyelin 
(SM), are predominantly localised in the outer layer while amine-containing phospholipids, 
phosphatidylserine (PS) and phosphatidylethanolamine (PE), are mainly confined to the inner 
layer. This asymmetry is maintained by 3 classes of transporters: aminophospholipid 
translocases (also known as flippases), floppases and scramblases. Flippases are responsible 
for the rapid transport of PS and PE back to the inner leaflet whereas floppases transport 
lipids non-selectively to the outer leaflet slowly. Both of these transporters are dependent on 
the presence of ATP. Scramblases, however, randomises phospholipid distribution in the 
bilayer, causing cells to lose membrane lipid asymmetry when stimulated by high Ca
2+
 
concentrations (Zwaal and Schroit, 1997; Daleke, 2003). PS externalisation, associated with 
the loss of membrane asymmetry, occurs during apoptosis or platelet activation for blood 
coagulation (Zwaal and Schroit, 1997; Lentz, 2003) and it is found to be an early event in 





Recognition of externalised PS on apoptotic cells via receptors on the phagocytes such as PS 
receptor (PSR) is essential for phagocytosis (Shiratsuchi et al., 1998; Schlegel et al., 2000; 
Greenberg et al., 2006). Phagocytosis via PS-PSR interactions suppress inflammatory 
responses through the release of anti-inflammatory mediators such interleukin 10 (IL-10), 
transforming growth factor beta (TGF-β) and prostaglandin E2 and the inhibition of pro-
inflammatory cytokines such as tumour necrosis factor alpha (TNF ), IL-12 and Il-1β (Savill 
and Fadok, 2000; Kim et al., 2005). The production of IL-10 and TGF-β also promotes the 
induction of alternatively activated macrophages which reduce nitric oxide production and 
inhibit T cell activation to prevent excessive inflammatory damage to host tissues (Noël et al., 
2004; Raes et al., 2007). 
 
1.4.3 PCD in multicellular organisms versus unicellular organisms 
In multicellular organisms, PCD is involved in the maintenance of homeostasis (cell renewal), 
embryonic development, organ regeneration and the regulation of the immune system, which 
is vital for normal development and functioning (Kim et al., 2005). Whereas in unicellular 
organisms, PCD may seem counterintuitive as it entails the death of the whole organism. 
However, there is increasing evidence for PCD in a wide variety of unicellular organisms as 
recently reviewed by Deponte (2008) and Shemarova (2010).  
 
It is now recognised that unicellular organisms live in communities in which they 
communicate and it is thought that the death of an individual via PCD could be beneficial for 
the population. This is particularly important in parasite populations which occupy one host 
and the death of the host means the death of the entire population. In addition, it has been 
observed that parasites can not only undergo PCD themselves but are able to manipulate host 
cell apoptosis. PCD, both in parasites and their hosts, is speculated to be essential to the 
parasitic lifestyle (James and Green, 2004; Bruchhaus et al., 2007; Lüder et al., 2010). This 




1.4.4 Apoptosis: protozoan parasites 
Parasites are dependent on their host for survival. Hence, to establish sustained infections and 
to allow for transmission into new hosts, it is important to ensure that the host is not quickly 
overwhelmed with hyperparasitemia. Apoptosis of the parasites presents a way to control 
parasite population by sacrificing some individuals to maintain a sustainable host-parasite 
balance. This has been observed in Trypanosoma brucei, the parasite which causes sleeping 
sickness in humans. It has been found that at a certain parasite density, replication is inhibited 
by differentiation into the non-dividing short stumpy form which produces prostaglandin D2 
(PGD2) and in turn, this induced apoptosis in these cells (Vassella et al., 1997; Figarella et al., 
2005). 
 
Apoptosis in parasites have also been used to facilitate their invasion of host cells. 
Leishmania is an intracellular parasite that causes a range of diseases, from cutaneous 
leishmaniasis resulting in skin lesions to the potentially fatal visceral leishmaniasis affecting 
vital organs. These parasites preferentially infect macrophages and it has been shown that 
Leishmania amastigotes expose PS on their surface to induce macrophage recognition and 
phagocytosis. This was termed “apoptotic mimicry” (De Freitas Balanco et al., 2001; Uzonna, 
2012). A similar observation was made in Toxoplasma gondii, another intracellular protozoan 
parasite, as well (Dos Santos et al., 2011). 
 
An added advantage of parasites dying by apoptosis is the dampening of the host immune 
response as macrophages that phagocytose “dying” parasites, via PS-PSR interactions, 
produce anti-inflammatory mediators and suppress pro-inflammatory mediators. This is 
essential for a sustained infection. TGF-β and/or IL-10 production by host macrophages was 
observed in Leishmania spp, Toxoplasma gondii and Trypanosoma cruzi infections (De 
Freitas Balanco et al., 2001; Seabra et al., 2004; Damatta et al., 2007). This is thought to have 
contributed to the survival of other non-apoptotic parasites (Van Zandbergen et al., 2006) and 
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blocking PS on the parasites resulted in higher host mortality due to inflammatory imbalance 
(Dos Santos et al., 2011). 
 
1.4.5 Modulation of host cell apoptosis: protozoan parasites 
Parasite infection often leads to the death of the host cell and the ability to control how and 
when the cell dies is important for parasite perpetuation. Different parasites have developed 
the capability to inhibit or promote apoptosis in a variety of host cells; the purpose of which 
depends on their mechanism of infection, intracellular or extracellular and even their stage of 
infection. Modulation of host apoptosis has been found to play a significant role in disease 
pathogenesis and outcome. The delay or inhibition of apoptosis has been implicated in 
prolonging cell life for parasite survival and spread while the induction of apoptosis is 
involved in immune evasion (through different cell types and pathways), facilitating parasite 
dissemination, supplying parasites with nutrients and growth factors and also crossing cell 
barriers (James and Green, 2004; Schaumburg et al., 2006; Bruchhaus et al., 2007; Rodrigues 
et al., 2012). 
 
For instance, in the intracellular Leishmania, neutrophils are the initial cells recruited to the 
site of infection following the insect bite and they phagocytose Leishmania promastigotes 
which survive within the cell. Neutrophils are short lived cells (6 to 10 hours); however, the 
parasite is able to delay neutrophil apoptosis, awaiting the second wave of infiltration by 
monocytes/macrophages, their preferred target cells (Aga et al., 2002). Infected neutrophils 
act as the intermediary cells for Leishmania infection of macrophages by eventually 
undergoing apoptosis. These apoptotic cells are ingested by the incoming macrophages which 
not only cause the down-regulation of host inflammatory response, but also become infected 
themselves (Ribeiro-Gomes et al., 2004; van Zandbergen et al., 2004). Leishmania was found 
to also inhibit macrophage apoptosis (Moore and Matlashewski, 1994) and enhance T cell 
apoptosis (Das et al., 1999; Pinheiro et al., 2004). Both of which contribute to the spread and 
12 
 
survival of Leishmania through increasing host cells available for infection and uptake by the 
vector while limiting effective anti-parasitic activity for unrestricted propagation. 
 
Another striking example is Cryptosporidium parvum, an intracellular but extracytoplasmic 
parasite, which primarily infects the intestinal epithelium. C. parvum has been shown to 
inhibit or induce apoptosis in the same host cells, depending on the developmental stage 
(Hijjawi et al., 2002; Mele et al., 2004). At the beginning of the infection as sporozoites bind 
to host cells and form the parasitophorous vacuole, apoptosis is induced in host cells. During 
the trophozoite stage, however, apoptosis is inhibited. Then finally, at the merozont/merozoite 
stage, apoptosis is triggered again (Mele et al., 2004; Barta and Thompson, 2006). As the 
parasite is developing, it is important to sustain the host cell but when the merozoites emerge 
from the cell, the down-regulation of anti-parasitic activity via apoptosis aid in its 
perpetuation.  
 
For extracellular parasites without the protection of host cells, immune evasion is essential for 
survival. Trypanosoma brucei does this partly by inducing selective apoptosis of 
lymphocytes, thus impairing the host adaptive immunity (Radwanska et al., 2008; Happi et 
al., 2012). Entamoeba, on the other hand, stimulates apoptosis in a contact-dependent manner 
which reduces necrosis and inflammation upon phagocytosis. Apoptotic cells also provide an 
important nutrient source for Entamoeba while promoting barrier dysfunction, hence allowing 
the parasite access to deeper tissues (Seydel and Stanley, 1998; Boettner and Petri, 2005; 
Becker et al., 2010). 
 
1.4.6 Parasite apoptosis and modulation of host apoptosis: malaria 
In the case of malaria, it has been found that while thousands of gametocytes get taken up in a 
blood meal by the mosquito, very few eventually develop into ookinetes and oocysts (Ghosh 
et al., 2000). Investigation of this phenomenon has shown that a large number of ookinetes 
undergo apoptosis and this occurs independently of mosquito immune factors, although they 
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can work synergistically (Al-Olayan et al., 2002). After the formation of ookinetes, they 
transverse the mosquito midgut epithelium by invading epithelial cells. These injured cells are 
extruded into the gut lumen and can cause substantial damage to the midgut epithelium. It is 
proposed that ookinete apoptosis occurs to reduce parasite load and hence, limit vector 
damage. This may be a response to the evolutionary pressure to prolong vector survival for 
parasite transmission while still maintaining the infection. Reducing parasite load also results 
in the conservation of nutrient resources, thus maximising the fitness of remaining parasites 
(Hurd and Carter, 2004; Hurd et al., 2005). 
 
During the establishment of the erythrocytic stage, Plasmodium merozoites are liberated to 
invade other erythrocytes. Some merozoites may not be successful in invasion and it has been 
shown that liberated merozoites are capable of externalising PS (Heussler et al., 2006). It is 
plausible to believe that phagocytes such as Kupffer cells recognise and phagocytose these 
merozoites silently without alerting the host immune system which is beneficial to the 
parasite.  
 
Apart from parasite PCD, Plasmodium infections are also known to affect apoptosis in 
various host cell types. In the murine malaria model for P. berghei, it was found that after 
sporozoites are injected into the host, they rapidly move to the liver through the bloodstream 
and enter the liver sinusoids. The sporozoites transverse the sinusoidal layer via Kupffer cells 
to reach the hepatocytes (Prudêncio et al., 2006). They then transmigrate through several 
hepatocytes before finally infecting one hepatocyte with the formation of a PV (Mota et al., 
2001). The wounded cells secreted hepatocyte growth factor (HGF) which not only made 
other hepatocytes more susceptible to infection, but HGF/MET (the HGF receptor) signalling 
also inhibited hepatocyte apoptosis in the early stage of infection (Leirião et al., 2005; van de 
Sand et al., 2005). Following which, viable parasites within the infected hepatocytes are 
required for continual inhibition of apoptosis (Van de Sand et al., 2005; Prudêncio et al., 
2006). Similar to Leishmania and Cryptosporidium, host cell survival is essential during 
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parasite development. However, during parasite egress, this inhibition was reversed and 
hepatocytes were instead, induced to undergo a form of PCD which was distinct from 
necrosis and apoptosis. During the late liver stage when hepatic schizonts were differentiated 
into merozoites, the PV membrane was disrupted and the merozoites were released into the 
hepatocyte cytoplasm. This initiated cysteine protease-mediated destruction of hepatocyte 
organelles. The infected cell detached from the neighbouring cells and budded off into 
merosomes (vesicles filled with merozoites) which entered the liver sinusoids (Sturm et al., 
2006; Vaughan et al., 2012). The membrane surrounding the merosomes was of host cell 
origin and it was found that PS asymmetry of the membrane was retained (Graewe et al., 
2011). While the destruction of organelles such as mitochondria resulted in the release of Ca
2+
 
which can activate scramblase to randomise phospholipid distribution, hepatic merozoites 
were shown to actively accumulate intracellular Ca
2+
 to prevent this (Sturm et al., 2006; 
Sturm and Heussler, 2007; Heussler et al., 2010). This allowed them to avoid detection by 
immune cells, in particular Kupffer cells, and the merozoites were safely transported out into 
the blood circulation for release and infection.  
 
In humans, the malaria liver stage is the least studied due to limited accessibility and much of 
what we know is almost exclusively reliant on murine malaria models, often with the idea that 
similar observations are likely to exist in other Plasmodium species including those infecting 
humans (Heussler et al., 2010). However, in a recent study, it was observed that while P. 
yoelii (another murine model) and P. falciparum sporozoites also transversed across cells 
before infecting the chosen hepatocyte, there was no HGF/MET signalling (Kaushansky and 
Kappe, 2011). More studies need to be done in order to find out if a different signalling 
pathway is used in these species to culminate a similar result.  
 
Increased host apoptosis is generally associated with malaria blood stage infections. This 
phenomenon is frequently studied in peripheral blood cells and the spleen (Baldé et al., 1995; 
Toure-Balde et al., 1996; Balde et al., 2000; Helmby et al., 2000; Ma, 2009; Kapoor et al., 
15 
 
2011). The spleen is a major organ involved in parasite clearance and it is divided into red 
pulp and white pulp regions, separated by the marginal zone. Blood passes through the red 
pulp where infected erythrocytes are mechanically trapped due to increased rigidity and 
parasites are squeezed out of the erythrocytes (pitting). These are rapidly phagocytosed by red 
pulp macrophages. In addition, parasite antigens are picked up by splenic dendritic cells 
which, in turn, help generate parasite-specific responses in T and B cell populations in the 
white pulp (Engwerda et al., 2005; del Portillo et al., 2012). It is found, during a malarial 
infection, the number of apoptotic mononuclear cells such as macrophages, T cells and B 
cells increase rapidly in the spleen (Helmby et al., 2000). This is accompanied by elevated 
serum levels of soluble Fas ligand and the upregulation of Fas expression in splenic cells. 
Hence, Fas- Fas ligand interactions are suspected to be involved in the induction of apoptosis 
(Helmby et al., 2000; Kern et al., 2000; Matsumoto et al., 2000). Furthermore, studies have 
found that apoptosis is selectively induced in parasite-specific T cells (Wipasa et al., 2001; 
Kemp et al., 2002a; Xu et al., 2002). This is significant as it indicates a deliberate attempt by 
the parasite to manipulate the host immune system. As a whole, apoptosis of mononuclear 
cells contribute to 1) suppression of inflammatory mediators as the apoptotic cells are cleared 
via phagocytosis and 2) reduced number of immune cells which impairs the ability of the host 
to mount an effective response; both of which favour parasite expansion and perpetuation 
(Kemp et al., 2002b; Xu et al., 2002). 
 
Apoptosis in endothelial cells are also widely reported, although whether this process is 
mediated by soluble factors or contact-dependent is still controversial (Pino et al., 2003; 
Hemmer et al., 2005; Touré et al., 2008; Wilson et al., 2008). Endothelial cell apoptosis has 
been observed to occur early in malaria pathogenesis (Touré et al., 2008); it could result in the 






1.4.7 Erythrocytes and malaria – cytoadherence and apoptosis? 
In a previous section we discussed the relationship of erythrocyte cytoadherence and malaria 
pathogenesis. Interestingly, it has been found that PS externalisation is correlated to increased 
cytoadherence (Schlegel et al., 1985; Tait and Smith, 1999; Manodori et al., 2000; Eda and 
Sherman, 2002). In the study by Eda and Sherman (2002), Annexin V (a calcium-dependent 
PS binding protein) was used to investigate PS exposure in infected erythrocytes and to 
inhibit PS-mediated erythrocyte binding to target molecules. They reported that as the malaria 
parasites matured, an increasing number of infected erythrocytes exposed higher levels of PS 
molecules on their cell surfaces (Figure 1.3).   
 
 
Figure 1.3 Histograms of PS exposure in Annexin V- FITC- and propidium iodide-labelled P. 
falciparum strain FCR-3- infected erythrocytes at different parasite developmental stages. (A) 
Uninfected erythrocytes (B) Ring-staged infected erythrocytes at 9.5% parasitemia (8.7% 
rings, 0.8% schizonts) (C) Enriched early trophozoite-staged infected erythrocytes at 61.5% 
parasitemia (D) Enriched late trophozoite / schizont-staged infected erythrocytes at 58.9% 
parasitemia (51.4% trophozoites, 7.5% schizonts). For (C) and (D), only PI-positive infected 





Experiments showed that PS binds to CD36 and thrombospondin (Table 1.1), which are also 
known to bind to PfEMP1 (Baruch et al., 1996; Tait and Smith, 1999; Manodori et al., 2000; 




Annexin V (µg/ml) 
Infected erythrocyte binding (% of control) 
Targets 
CD36 thrombospondin 
0 100 100 
25 88.8 ± 31.9 63.3 ± 4.4 
50 19.5 ± 13.6 49.5 ± 6.5 
100 34.5 ± 20.6 46.1 ± 5.4 
Table 1.1 Effects of Annexin V on the binding of P. falciparum strain FCR-3- infected 
erythrocytes to target proteins, CD36 and thrombospondin. The target proteins were 
immobilised on slides and incubated with infected erythrocytes pretreated with the stated 
concentrations of Annexin V. The number of bound cells/mm
2
 area of immobilized protein 
was determined via light microscopy. Control values of FCR-3-infected erythrocyte binding 
(0µg/ml Annexin V) to CD36 and TSP were 1092 ± 81 infected cells/mm
2
 and 2777 ± 110 
infected cells/mm
2
 respectively. Each value represents the mean ± SD of triplicate 
determinations. Similar results were obtained in two or three separate experiments.  (Table 




We know PS externalization is also involved in apoptosis and phagocyte recognition. As 
mentioned, externalised PS serve as “eat-me” signals for phagocytes which possess specific 
receptors to recognize PS on the apoptotic bodies/cells and proceed to engulf them 
(Shiratsuchi et al., 1998; Hoffmann et al., 2001). However, studies (Anderson et al., 2002; 
Gregory and Devitt, 2004; Segawa et al., 2011) have shown that PS exposure during 
apoptosis, while necessary, is not sufficient to cause phagocytosis. An essential receptor co-
factor in the recognition of apoptotic bodies is CD36 (Maderna and Godson, 2003; Patel et 
al., 2004; Greenberg et al., 2006).  
 
Hence, we raise the questions  
1) Does PS play an additional role in malaria pathogenesis? Is apoptotic mimicry 
(similar to Leishmania) involved? 




1.5 Study Objectives  
It is reported that PS externalisation in malaria-infected erythrocytes only occur in the later 
stages of parasite development and it is absent in the early ring stages. The maturation of the 
ring stage parasites to trophozoites takes about 24 hours. However, in Eda and Sherman 
(2002), the maturity of the ring-staged cells analysed was not stated and PS externalisation of 
ring-staged infected erythrocytes was only captured at a single time point. Hence, it is 
necessary to explore PS externalisation in infected erythrocytes at more time points, 
particularly in the ring stage.  
 
We hypothesized that PS externalization in infected erythrocytes could result in increased 
phagocytosis and reduced inflammation, akin to the “apoptotic mimicry” theory displayed in 
Leishmania. However, in order to investigate this, we need to exclude the involvement of 
PfEMP1 which competes with PS for receptors like CD36. PfEMP1 is encoded by the var 
multigene family and can only be detected on the surface of infected erythrocytes from 16 
hours onward after invasion (late ring-early trophozoite stage; (Kyes et al., 2001; Frankland et 
al., 2006). While both PS and PfEMP1 have been demonstrated to contribute to the 
“stickiness” of infected erythrocytes, sequestration of infected erythrocytes is generally 
attributed to PfEMP1 as the later staged infected erythrocytes are often absent in peripheral 
circulation. It has been revealed that pretreatment of phagocytes with PS liposomes did not 
inhibit experimental phagocytosis of infected erythrocytes containing trophozoite-stage 
parasites (Serghides and Kain, 2001). Hence it is plausible that PfEMP1 on the cell surface 
may supersede PS as the ligand for phagocytic recognition, only in the later developmental 
stages. In addition, we know that the spleen is a major organ involved in parasite clearance 
and parasite-specific responses in T and B cell populations are generated in the white pulp 
region of the spleen (Engwerda et al., 2005; del Portillo et al., 2012). Since much of the later 
staged infected erythrocytes are sequestered (Pongponratn et al., 1991), ring-staged infected 
erythrocytes dominates the infected cell population during splenic clearance but there have 
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been few reports focussing on ring-staged infected erythrocytes. It is, therefore, important to 
study and compare the relationships of different parasite stages with phagocytosis.  
 
Also, certain diseases such as sickle-cell anaemia, thalassemia and glucose-6-phosphate 
dehydrogenase (G6PD) deficiency have been associated with increased eryptosis and 
protection against malaria (Zwaal et al., 2005; Williams, 2006; Lang and Qadri, 2012). 
Protection is thought to be due at least in part to enhanced phagocytosis of infected 
erythrocytes (Cappadoro et al., 1998; Ayi et al., 2004; Lang et al., 2009) which reduces the 
host parasitemia and subsequent pathologies. However, phagocytosis of apoptotic self cells, 
albeit infected cells, may suppress host inflammatory response through the release of anti-
inflammatory mediators which is beneficial for parasite survival and perpetuation. Looking at 
the changes in anti- and pro-inflammatory cytokine production of phagocytes after 
phagocytosis may offer some insights into this theory. 
 
Understanding of the mechanism of infection by P. falciparum is critical in its treatment and 
prevention. In this study, we attempt to: 
1) Validate the levels of PS exposure in the erythrocytes throughout the 48-hour 
erythrocytic developmental cycle of P. falciparum.  
2) Explore the identity of the parasite factor which causes PS externalisation in 
erythrocytes.  
3) Compare the phagocytic uptake of P. falciparum-infected erythrocytes of different 
parasite developmental stages under different conditions. 
4) Inhibit PS-mediated phagocytosis in these infected erythrocytes of different parasite 
developmental stages via Annexin V. 















MATERIALS AND METHODS  
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2.1 Plasmodium  falciparum Parasites 
2.1.1 Parasite culture and blood smears 
P. falciparum NF54 (Netherlands) strain 3D7 clone (MRA-102, MR4, ATCC
®
), in vitro 
cultures were maintained in 75 cm
2
 or 150 cm
2 
flasks with human erythrocytes (blood group 
O
+
, erythrocytes with less than 2 weeks of storage at 4C) at 1% hematocrit. The malaria 
culture media (MCM) used consisted of RPMI 1640 medium supplemented with 0.5% (w/v) 
albumax II (Gibco), 2 mM L-glutamine (Sigma-Aldrich), 0.3 mM hypoxanthine (Sigma-
Aldrich) and 25 µg/ml gentamycin (Gibco). The cultures were gassed with 5% CO2 (v/v) and 
3% O2 (v/v) balanced with N2 and kept at 37C in a dark incubator. Subculturing and medium 
replacement were done on alternate days. 
 
Thin blood smears stained with Giemsa were used to determine parasite developmental stage 
and parasitemia, before subculturing, synchronisation and prior to each experiment. The 
culture flask was shaken gently to homogenize the culture; a 300 µl aliquot was taken and 
centrifuged at 750 g for 1 minute. Most of the supernatant was removed and the erythrocyte 
pellet was resuspended in the remaining supernatant before being smeared evenly across a 
glass slide, using another clean glass slide. The smear was blown dry using a hairdryer and 
fixed using methanol. Giemsa (Merck) was diluted in the ratio of 1 in 6 parts of water. The 
fixed smear was stained with 3 ml diluted Giemsa for 10 minutes and excess stain was 
washed off with water. The smear was blot-dried and viewed under oil-immersion at 1,000 
times magnification, using a typical optical light microscope.  
 
2.1.2 Preparation of human erythrocytes 
Blood used for parasite cultures was collected from healthy human volunteers in tubes 
containing sodium-citrate-dextrose at National University Hospital Blood Bank (IRB number: 
10-189). Whole blood was washed once with RPMI 1640 and the supernatant was aspirated. 
14 ml of citrate phosphate dextrose adenine-1 (CPDA-1) was added for every 100 ml of 
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packed erythrocytes and left to incubate at 4 °C for three days. After which, the cells were 
washed three times with RPMI 1640 and centrifuged at 600 g for 10 minutes (without 
brakes). In order to obtain only erythrocytes, the supernatant, along with the buffy coat layer, 
was discarded after each wash. Erythrocytes were then resuspended in an equal volume of 
MCM and stored at 4 °C for use. 
 
2.1.3 Parasite synchronisation 
Synchronisation of parasites was typically done twice weekly using a modified 5% D-sorbitol 
lysis method, originally described by Lambros and Vanderberg (1979). Briefly, 30 ml of 1% 
hematocrit parasite culture was centrifuged at 600 g for 5 minutes. The supernatant was 
aspirated and the erythrocyte pellet was resuspended with 15ml of 5% D-sorbitol (w/v). The 
suspension was placed in a 37C water bath for 10 minutes, with occasional shaking. The 
suspension was then centrifuged at 600 g for 5 minutes and washed with 20 ml of MCM. This 
step was repeated twice before proceeding with normal subculturing. This method specifically 
lysed later trophozoite and schizont stages, leaving only uninfected and ring-staged infected 
erythrocytes intact. 
 
Double-synchronisation of parasite cultures was done when parasite cultures of high 
synchrony were required for experiments. The first synchronisation step was carried out when 
the parasites had just invaded the erythrocytes and early ring stages (0 to 6 hours) were 
formed. The second synchronisation step was done 18 hours later when the parasites had 
developed further (18 to 24 hours). Following which, these cultures were then subcultured as 








2.2 Assays with Annexin V for Determining Phosphatidylserine Externalisation 
2.2.1 Annexin V assay for phosphatidylserine externalisation 
Annexin V-fluorescein isothiocyanate (Annexin V-FITC; Biovision) bind to 
phosphatidylserine molecules. 1 ml of cells at 1% hematocrit was transferred to 1.5 ml 
microfuge tubes. The cells were centrifuged and the supernatant was replaced with 1 ml of 
Annexin V binding buffer (Biovision) containing Ca
2+
 necessary for Annexin V binding. Ten 
µl of stock Annexin V-FITC was added to every 1 ml of cells at 1% hematocrit. A final 
concentration of 1 µg/ml Hoechst 33342 (Molecular Probes
®
) and 100 ng/ml propidium 
iodide (PI) were also added to verify parasitemia and the presence of necrotic cells 
respectively, depending on the experiment (when parasite cultures were used). Hoechst 33342 
is a membrane-permeable DNA binding stain whereas PI is membrane impermeant and will 
only label cells with compromised membranes. The cells were incubated at 37C for 10 
minutes prior to flow cytometry analysis.  
 
2.2.2 Determination of phosphatidylserine externalisation throughout parasite erythrocytic 
cycle 
Parasite cultures were subjected to a round of double synchronisation and allowed to recover 
for one cycle; followed by another round of synchronisation before they were used in these 
experiments. A parasitemia of approximately 5% with > 90% of early rings (4 to 8 hours) was 
determined with a blood smear prior to the start of the experiment before the cells were 
assayed for phosphatidylserine externalisation with Annexin V-FITC, PI and Hoechst 33342. 
This was repeated at 7-hour intervals throughout the 48-hour cycle of the parasite. 
 
2.3 Experiment using Spent Culture Media 
2.3.1 Collection of spent culture media 
The parasitemia of unsynchronised parasite cultures was determined with a blood smear. 200 
ml of parasite culture was centrifuged at 600 g for 5 minutes. The supernatant was aspirated 
and replaced with an equal volume of fresh MCM. The culture was diluted to parasitemias of 
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2%, 5% and 10% at 1% hematocrit, using fresh erythrocytes and MCM, in 3 separate flasks of 
100 ml each. The cultures were gassed with 5% CO2 (v/v) and 3% O2 (v/v) balanced with N2 
and incubated at 37C for 48 hours. The cultures were then centrifuged at 600 g for 5 minutes. 
The supernatant of these three flasks were collected and used in the same day. 
 
2.3.2 Treatment of culture media 
The collected spent MCM from parasite cultures of 2%, 5% and 10% parasitemia, along with 
fresh MCM, were subsequently treated under various conditions including: 
1. Addition of 2% bovine serum albumin (w/v) (Sigma-Aldrich),  
2. Filtration using a 0.22 µm syringe filter, 
3. Filtered using a 0.22 µm syringe filter, followed by the addition of 2% bovine serum 
albumin, 
4. Centrifugation at 800 g for 5 minutes, 
5. Centrifugation at 15,000 g for 5 minutes, 
6. 5 cycles of alternate freezing with liquid nitrogen and thawing using a 37C water 
bath, 
7. Heat treatment of 65C for 30 minutes, followed by cooling to 37C before use, 
8. Heat treatment of 95C for 30 minutes and cooled to 37C before use, 
9. Heat treatment of 65C for 30 minutes, followed by filtration using a 0.22 µm syringe 
filter and cooling to 37C before use. 
 
2.3.3 Incubation of treated culture media with pure uninfected erythrocytes 
Treated media were added to pure uninfected erythrocytes to a final hematocrit of 1%. Fresh 
MCM and untreated spent MCM from cultures at parasitemias of 2%, 5% and 10% were 
included in the conditions for comparison. The uninfected erythrocytes and spent culture 
media were incubated at 37C for 4 hours before assaying for phosphatidylserine 
externalisation in the uninfected erythrocytes with Annexin V-FITC, Hoechst 33342 and PI. 
25 
 
Hoechst and PI were used to exclude the possibility of carryover infected cells from the spent 
media. 
 
2.4 THP-1 Cells 
2.4.1 Monocyte culture and macrophage differentiation 
Non-adherent human monocytic cell line THP-1 (provided by Dr Sylvie Alonso, Immunology 
Programme, NUS) was maintained in 150 cm
2
 flasks with THP-1 culture medium consisting 
of RPMI 1640 medium supplemented with 10% (v/v) heat-inactivated fetal bovine serum 
(Gibco), 2 mM L-glutamine, 100 units/ml penicillin and 100 ug/ml streptomycin. Serum heat 
activation was done at 56C for 30 minutes. The cells were subcultured every 3 days and cell 
density was maintained at less than 2 x 10
5 
cells per ml. Cultures were kept in a humidified 
37C incubator with 5% (v/v) CO2 and 95% (v/v) air. A viable count was done on THP-1 
cells using a haemocytometer and trypan blue for subculturing and prior to experiments.  
 
THP-1 cells were centrifuged at 350 g for 5 minutes and resuspended in fresh THP-1 culture 
medium. The cells were counted and seeded at 5 x 10
5
 cells per well in 12-well plates 
(Greiner Cellstar
®
) or at 2 x 10
5
 cells per well in 24-well plates (Greiner Cellstar
®
), depending 
on the experiment carried out. The volume of each well was made to 3 ml in 12-well plates 
and 1.5 ml in 24-well plates, with THP-1 culture media.  
 
To obtain macrophages, the cells were differentiated using 10 ng/ml phorbol 12-myristate 13-
acetate (PMA; Sigma-Aldrich, Dorset, UK) for 24 hours in 5% (v/v) CO2 at 37C.  The 
supernatant and unattached cells were removed by aspiration and adherent macrophages were 
washed twice with THP-1 culture medium before the wells were filled with fresh THP-1 





2.4.2 Expression of cell surface markers on THP-1 cells 
Expression of cell surface markers, CD36 and CD68, were compared between THP-1 
monocytes and differentiated macrophages to ensure successful differentiation. The 
differentiated cells were washed twice with phosphate-buffered saline (PBS) and incubated 
with warmed cell-lifting reagent (PBS with 5mM EDTA and 10mM D-glucose, pH 7.2) for 
10 minutes at 37C before being detached gently by repeat pipetting. Both monocytes and 
differentiated macrophages were washed, resuspended in 200 µl of PBS and incubated with 
16 ul APC-Cy7-conjugated antihuman CD36 or 40 ul PE-conjugated antihuman CD68 
(provided by Dr Wong Siew Cheng, Singapore Immunology Network, A
*
STAR) for 30 
minutes at 4C. They were then washed thrice with 1ml PBS and resuspended in 500 µl of 
PBS before flow cytometric analysis. 
 
2.5 Establishment of the Phagocytic Assay 
2.5.1 Erythrocyte cytoplasm and parasite DNA labelling   
To optimise the dihydroethidine (DHE) concentration necessary to clearly visualise the 
parasites, synchronised ring-staged cultures at 1% hematocrit were stained with various 
concentrations of DHE (5, 10, 25 and 50 µg/ml; Molecular Probes
®
) for 20 minutes at 37C, 
with occasional mixing. The cells were washed twice with equal volume of PBS and 
resuspended in PBS for flow cytometry analysis. 
 
Ethidium bromide (EB) is a membrane-impermeant stain which had been previously used to 
label parasite DNA (Tippett et al., 2007). For comparison, ring cultures were also stained with 
10 µg/ml EB or varying concentrations of DHE, in combination with 1 µg/ml Hoechst 33342, 
for 20 mins at 37C. These labelled parasite cultures were washed with 1 ml PBS twice before 





In the phagocytic experiments, parasite cultures were centrifuged at 600 g for 3 minutes to 
pellet the erythrocytes. The supernatant was removed and the pellet was resuspended in PBS 




) at 1% 
hematocrit for 20 mins at 37C, with occasional mixing. Labelled erythrocytes were 
incubated for 5 minutes at 37C with 10 volumes of fresh MCM to quench unbound 
CellTrace
TM 
Violet and washed once before resuspension in MCM to 1% hematocrit for the 
incubation with phagocytes. 
 
2.5.2 Determination of effector: target ratios in phagocytic assays  
For phagocytic assays, the cells were counted and seeded at 2 x 10
5
 cells per well in 24-well 
plates. DHE- and CellTrace
TM
 Violet- labelled pure uninfected erythrocytes or ring-staged 
cultures (ring culture) were added to wells containing THP-1 monocytes or macrophages at 
varying effector (E) to target (T) ratios (from 1E:10T to 1E:260T, where the effectors were 
THP-1 cells and the targets were erythrocyte cultures. The cells were incubated together for 4 
hours at 37C in a humidified incubator with 5% (v/v) CO2 and 95% (v/v) air. 
 
Adherent THP-1 macrophages were washed with PBS twice to remove unphagocytosed 
erythrocytes. The cells are then treated with 500 µl 0.25% trypsin-EDTA (Gibco) for 5 
minutes at 37C to detach them and washed in 2 volumes of THP-1 culture medium to 
remove trypsin present in the medium.  
 
For the monocytes, the cells were placed in 15 ml tubes and centrifuged at 35 0g for 5 
minutes. For each tube, the supernatant was aspirated and the pellet was resuspended in 1ml 
red cell lysis buffer (distilled water with 1.7mM Tris HCl, 0.14M ammonium chloride at pH 
7.4) at 37C for 8 minutes with frequent agitation, to lyse the unphagocytosed erythrocytes 
before being washed twice with 10 volumes of THP-1 culture media. After which, both 
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monocytes and macrophages were then resuspended in 500 µl PBS for flow cytometric 
analysis. 
 
Subsequent phagocytic experiments were carried out with the optimal E:T ratio of 1:100.  
 
2.5.3 Validation controls for phagocytic assay  
THP-1 monocytes and PMA-differentiated THP-1 macrophages were incubated with DHE- 
and CellTrace
TM
 Violet-labelled pure uninfected erythrocytes, ring cultures and schizont 
cultures for phagocytosis after the following treatments. 
 
To ensure the validity of the method, THP-1 phagocytes were preincubated with 5 µM 
cytochalasin D (Sigma-Aldrich), an actin polymerization inhibitor, for 1 hour at 37C prior to 
the addition of the labeled erythrocytes for phagocytosis. In addition, phagocytosis incubation 
was also carried out at 4C; however, due to the detachment of THP-1 cells and inconsistent 
results, only the results from cytochalasin D pretreatment were presented as the negative 
control, As a positive control, labelled erythrocytes were opsonised with heat-inactivated 
immune serum from P. falciparum-infected patients (P. falciparum (+) serum; a kind gift of 
Prof Francois Nosten, Shoklo Malaria Research Unit, Mae Sod, Tak Province, Thailand) for 
30 mins at room temperature and washed thrice with MCM before being added to THP-1 
phagocytes for phagocytosis. This was also done with heat-inactivated healthy control serum 
to ensure that any observed increase in phagocytosis was not an artefact. 
 
2.5.4 Test conditions using phagocytic assay 





Ten µg of unlabelled recombinant Annexin V (Biovision) was added per 10 million labelled 
erythrocytes in Annexin V binding buffer, 30 minutes before phagocytosis, to investigate the 
role of phosphatidylserine externalisation in phagocytosis; after which, the erythrocytes were 
incubated with the THP-1 phagocytes (without washing off Annexin V).  For the control 
(phagocytes alone), the same volume of Annexin V binding buffer, together with 10 µg 
Annexin V, was added directly to the phagocytes. 1 µg/ml of Lipopolysaccharides (LPS) 
from Salmonella enteric serotype typhimurium (Sigma-Aldrich) or 5 µM cytochalasin D was 
added to phagocytes 1 hour prior to phagocytosis to activate the cells. Other conditions 
involved a combination of the different treatments mentioned: 1) 10 µg unlabelled Annexin V 
per 10 million erythrocytes, together with preincubation of phagocytes with 1 µg/ml of LPS; 
2) Preincubation of phagocytes with 1 µg/ml of LPS and 5 µM cytochalasin D 
 
After phagocytic incubation, phagocytes were prepared for flow cytometric analysis. 
 
2.6 Cytokine Assays 
2.6.1 Culture supernatant collection for measurement of cytokine release from phagocytes 
For supernatant collection, the cells were seeded at 5 x 10
5
 cells per well in 12-well plates and 
prepared as mentioned previously, depending on whether the phagocytes used were 
monocytes or differentiated into macrophages. Unlabelled pure uninfected erythrocytes, ring 
cultures and schizont cultures were incubated with THP-1 monocytes and PMA-differentiated 
THP-1 macrophages for phagocytosis after carrying out the stated treatments. 
1) Untreated erythrocytes and phagocytes 
2) 30 minutes incubation of 10 µg unlabelled Annexin V per 106 erythrocytes 
3) 1 hour incubation of 1 µg/ml of Lipopolysaccharides (LPS) from Salmonella enteric 
serotype typhimurium with the phagocytes 
4) 1 hour incubation of 5 µM cytochalasin D with the phagocytes 
5) 10 µg unlabelled Annexin V per 10 million erythrocytes, together with preincubation 
of phagocytes with 1 µg/ml of LPS 
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6) Preincubation of phagocytes with 1 µg/ml of LPS and 5 µM cytochalasin D 
 
Phagocytosis was carried out for 4 hours at 37C in a humidified incubator with 5% (v/v) 
CO2 and 95% (v/v) air. After which, unphagocytosed erythrocytes were removed through 
washing and/or erythrocyte lysis. 1 ml of fresh THP-1 culture media was added to the wells. 
Phagocytes were incubated a further 24 hours before the supernatant was collected and spun 
down to remove any cells. The supernatant was aliquoted and stored at -80C prior to use. 
 
2.6.2 Measurement of cytokines released by phagocytes after phagocytosis of P. falciparum 
cultures  
For the quantitative measure of cytokines released by the phagocytes into the culture 
supernatant after phagocytosis, human cytokine ELISA development kits for interleukin 6 
(IL-6), interleukin 10 (IL-10) and tumour necrosis factor alpha (TNF ) were used (all 
purchased from PeproTech). The detection ranges (lower-higher limits) of the kits were as 
followed: IL 6 (32-2000 pg/ml); IL 10 (39-2500 pg/ml); TNF  (23-1500 pg/ml). 
 
2.6.3 Preparation and storage of antibodies and cytokine standards 
Capture antibodies (antigen-affinity purified goat anti-human IL-6, antigen-affinity purified 
rabbit anti-human IL-10 and antigen-affinity purified rabbit anti-human TNF , all with 2.5 
mg D-mannitol added) were reconstituted to 100 µg/ml with sterile water, aliquoted and 
stored at -20C.  
 
Detection antibodies (biotinylated antigen-affinity purified goat anti- human IL-6, 
biotinylated antigen-affinity purified rabbit anti-human IL-10 and  biotinylated antigen-
affinity purified rabbit anti-human TNF , all with 2.5 mg D-mannitol added) were also 




One µg of recombinant human cytokine standards (IL-6, IL-10 and TNF ), together with 2.2 
mg bovine serum albumin and 11 mg D-mannitol were reconstituted to 1 µg/ml with sterile 
water, aliquoted and stored at -20C. Avidin-HRP conjugate was also aliquoted and stored at -
20C. 
 
2.6.4 Enzyme-Linked Immunosorbent Assay (ELISA) – IL-6, IL-10 and TNF  
The protocols for the various cytokine assays were similar unless stated otherwise. The 
capture antibody was diluted 100 times with PBS to 1 µg/ml and 100 µl of this was added per 
well to 96-well plates (Nunc MaxiSorp®). The plates were sealed and incubated overnight for 
16 hours. After which, the wells were aspirated and washed 4 times, each time with 300 µl of 
wash buffer (0.05 % Tween-20 in PBS). After the final wash, the plates were inverted and 
blotted dry on paper towels. To block the remaining adsorptive surfaces, the wells were 
incubated with 300 µl of block buffer (1% bovine serum albumin in PBS) for at least 1 hour 
at room temperature. The wells were aspirated and the plates were blotted dry on paper 
towels.  
 
During the blocking step, the standards were prepared according to Table 2.1, using assay 
diluent (0.05% Tween-20, 0.1% bovine serum albumin in PBS). 
 
Table 2.1 Concentration of standards used in cytokine ELISA assays 
Cytokine Concentration (pg/ml) 
IL-6 2000 1500 1000 750 500 250 125 62.5 31.25 0 - 
IL-10 2500 2000 1500 1000 750 500 250 125 62.5 31.25 0 
TNF  1500 1000 750 500 375 187.5 93.75 46.875 23.4375 0 - 
 
100 µl of standards and undiluted samples were added to each well in duplicates or triplicates 
and incubated for 2 hours at room temperature. After which, the wells were aspirated and 
washed 4 times, each time with 300 µl of wash buffer (0.05% Tween-20 in PBS). After the 




The detection antibody was diluted with assay diluent 400 times (0.25 µg/ml) for IL-6, and 
200 times (0.5 µg/ml) for both IL-10 and TNF . One hundred µl was added per well and the 
plates were incubated for 2 hours at room temperature. Then, the plates were aspirated and 
washed 4 times. After the final wash, the plates were inverted and blotted dry on paper 
towels.  
 
Avidin-HRP conjugate was diluted 2000 times (5.5 µl in 11 ml diluent). One hundred µl was 
added per well and the plates were incubated for 30 minutes at room temperature. The plates 
were aspirated and washed 4 times. After the final wash, the plates were inverted and blotted 
dry on paper towels. One hundred µl of 2,2’-Azino-bis(3-ethylbenzothiazoline-6-sulfonic 
acid) liquid substrate (ABTS; Sigma-Aldrich) was added to each well and incubated at room 
temperature to allow for colour development. ABTS was equilibrated to room temperature 
before use. Colour development was monitored every 5 minutes with Tecan Infinite
®
 M200 
microplate reader at 405nm with a reference wavelength correction at 650 nm, using the i-
control™ software. The values required for reliable standard curves are such that the optical 
density readings do not exceed 0.2 units for the zero standard concentrations and 1.2 units for 
the highest standard concentrations. The set of readings which fulfilled these criteria was used 
for calculating and plotting the standard curves.  
 
2.7 Flow Cytometry and Confocal Imaging 
2.7.1 Flow cytometry analyses 
For flow cytometry, samples were acquired with CyAn ADP Analyzer (Dako/Beckman 
Coulter, Brea, CA, USA) and analyzed using the Summit software, version 4.3. The CyAn 
ADP Analyzer is fitted with 405 nm and 488 nm solid state lasers and a 635 nm red diode 
laser. Fluorescence detection was done using the following excitation (Ex) and emission (Em) 
wavelengths: Violet 1: Ex 405 nm, Em. 450/50 nm; FITC: Ex. 488 nm, Em. 530/40 nm; PE: 
Ex. 488 nm, Em. 575/25 nm; Texas Red: Ex 488 nm, Em. 613/20 nm; APC-Cy7: 633 nm, 




For analysis of PS externalisation in erythrocyte samples, erythrocytes were selected 
according to their forward and side scatter properties and PI-positive cells were gated away. 
The remaining events were displayed on Violet 1 (FL 6) fluorescence versus green FITC (FL 
1) fluorescence dotplots. Infected erythrocytes with externalised PS molecules were defined 
by a region set for dual-positive violet and green fluorescence and uninfected erythrocytes 
were defined by a region set for positive green fluorescence only. At least 100,000 events 
were collected for each erythrocyte sample.  
 
The THP-1 effector cells were selected according to their forward and side scatter properties 
using THP-1 cells alone as a control. Selected events were displayed on Violet 1 (FL 6) 
fluorescence versus Texas Red (FL 3) fluorescence dotplots. THP-1 cells containing 
phagocytosed CellTrace
TM 
Violet-labeled uRBCs were defined by a region set for violet 
fluorescence and those containing infected erythrocytes (labeled with both CellTrace
TM 
Violet- and DHE) were defined by a region set for dual-positive violet and red fluorescence. 
At least 20,000 events were collected for each phagocytic sample.  
 
2.7.2 Visualisation by confocal microscopy 
After phagocytic incubation, effector cells were labeled with 10 µl of stock FITC anti-human 
CD36 (Biolegend, CA, USA) for 30 minutes at 4C and washed 3 times with PBS before 
confocal imaging.  
 
To visualise infected erythrocytes, 10 µl of parasite culture was placed on a glass slide and 
sealed under a cover slip with clear nail varnish. For phagocytes, the cells were centrifuged 
and most of the supernatant was removed. The cell pellet was suspended with the remaining 
supernatant. A wet mount was then prepared with 10 µl of the cell suspension and sealed 




Confocal imaging was performed under 100X oil objectives using Olympus Fluoview 
FV1000 (Toyko, Japan) which is equipped with solid state and Argon ion lasers tuned to 405  
nm and 488 nm respectively. Images were viewed with the software Olympus Fluoview 
version 2.0A. 3D reconstruction was done using Imaris x64 version 6.1.5. 
 
2.8 Statistical Analyses 
Statistical signiﬁcance of differences between the experimental groups as indicated was 
analyzed by ANOVA with post-hoc comparison using Tukey’s test for paired comparisons. 
Signiﬁcantly different results (p  0.05) were highlighted. All statistical analyses were 
















3.1 PS Externalisation Throughout 48-hour Life Cycle of P. falciparum 3D7 
To determine the level of PS externalisation of both malaria-infected and uninfected 
erythrocytes (uRBCs), FITC-labelled Annexin V, PI and Hoechst 33342 were used to stain P. 
falciparum cultures of about 5% parasitemia. In comparison to pure uninfected erythrocytes, 
uninfected erythrocytes that have been incubated with P. falciparum display significantly 
higher levels of PS externalisation, regardless of developmental stage of the parasite (p < 
0.001). The uninfected erythrocytes in culture with parasites of the late schizont stage (about 
46 hours post invasion) showed significantly more PS exposure than those in culture with 
parasites of earlier stages (p < 0.001). Also, PS externalisation of uninfected erythrocytes in 
the parasite culture was the lowest when the parasites were at mid-ring stage (between 11 to 
15 hours of development; Figure 3.1A).  
 
In Figure 3.1B, only PI-negative and Hoechst-positive infected cells were analysed. PI-
positive cells are cells with compromised plasma membranes which may result in the leakage 
of Annexin V into the cells, leading to false positives. PS externalisation in cells infected with 
the early ring stage (about 4 to 8 hours into development) parasites are significantly higher 
than those infected with later stages, with the exception of those in late schizont stage (about 






Figure 3.1 Measurement of phosphatidylserine externalisation in erythrocytes from 3D7 P. 
falciparum cultures at different parasite developmental stages with a starting parasitemia of 
about 5 %. (A) Percentage of Annexin V positive uninfected erythrocytes (Hoechst negative) 
in parasite culture, with pure uninfected erythrocytes as a control (avb, avc, avd, ave, avf, avg, 
avh, bvh, cve, cvf, cvg, cvh, dvh, evh, fvh, gvh, p < 0.001; bvc, cvd, p < 0.01) (B) Percentage 
of Annexin V positive infected erythrocytes (Hoechst positive) in parasite culture (AvB, AvC, 
p < 0.001; AvD, AvE p < 0.01; AvF, CvG, p < 0.05). Data represent means ± SEM, n ≤ 3. 
The cells were labelled with FITC Annexin V, Hoechst 33342 and PI, and assayed at 7-hour 





3.2 Effect of Spent Parasite Media on PS Externalisation in Pure Uninfected 
Erythrocytes 
In order to investigate the phenomenon of PS externalisation in malaria-infected erythrocyte 
culture, spent culture media was used. After spent media was collected, it was immediately 
processed and incubated with uninfected erythrocytes for 4 hours at 37C, before assaying for 
PS externalisation with Annexin V-FITC.  
 
It is observed that with increasing parasitemia of the cultures from which the spent media was 
extracted, there was increasing amount of PS externalised in the uninfected erythrocytes. This 
was seen in various treatments of the spent media (Figure 3.2). In the untreated samples, PS 
externalisation of uninfected erythrocytes incubated with spent media from cultures of 5% 
parasitemia and 10% parasitemia was increased (p < 0.001) but there was no difference 
between fresh media and spent media from cultures of 2% parasitemia.  
 
During the processing of spent media, particulate matter was observed and it was thought to 
be hemazoin, the malarial pigment. Presence of hemin or hemazoin (black pigment) was 
involved in causing eryptosis and PS externalisation (Gatidis et al., 2009; Lamikanra et al., 
2009) and it was reported to be at least in part inhibited by the binding of human albumin and 
bovine serum albumin (Grinberg et al., 1999; Kumar and Bandyopadhyay, 2005). In Figure 
3.2A, 2 % w/v of bovine serum albumin was dissolved in the spent culture media of varying 
parasitemia before incubating with uninfected erythrocytes in attempt to inhibit PS 
externalisation. However, treatment with 2% albumin did not manage to prevent PS exposure. 
As both hemin and hemazoin are insoluble in water, the spent media was filtered with 0.2µm 
syringe filters to investigate if 1) the factor involved in causing PS externalisation was 
insoluble and 2) the size of this particular factor. Filtration with 0.2 µm filters abolished PS 
externalisation, with or without the addition of 2% albumin such that it was not different from 




Similarly, centrifugation of the spent media would give a hint of the size and weight of the 
factor involved in inducing PS externalisation. Centrifugation of spent culture media, at both 
800 g and 15000 g, managed to abolish PS externalisation (levels similar to untreated fresh 
media samples), compared to the corresponding untreated samples. However, freeze thawing 
the spent media for 5 cycles did not change the level of PS exposure compared to the 
untreated samples, which meant that the exposed PS measured was not due to an artefact of 
residual cells in the spent media (Figure 3.2B).  
 
To find out if the factor involved was heat labile, the spent culture media was heated at 65C 
and also at 95C before incubating with uninfected erythrocytes. Spent media from cultures at 
10% parasitemia increased the level of PS exposure in uninfected erythrocytes after heating 
(both p < 0.001) in comparison to the untreated sample at the same parasitemia. 
Centrifugation (at 800 g) of the heated spent media brought PS exposure levels back to that of 






Figure 3.2 Effect of spent media (from parasite cultures of different parasitemias: 10 %P, 5 
%P, 2 %P and fresh media) on PS externalization of pure uninfected erythrocytes after 4h 
incubation. (A) Effect of filtration and presence of albumin: spent media was either filtered 
with 0.2 µm syringe filter and/or incubated with 2 % bovine serum albumin before incubation 
with uninfected erythrocytes, (B) Effect of centrifugation and freeze-thawing: spent media 
centrifuged at 800 g, 15,000 g or freeze-thawed for 5 cycles before incubation with uninfected 
erythrocytes and (C) effect of temperature: spent media was heated at 65C,  95C or heated 
at 65C before centrifugation at 800 g and incubated with uninfected erythrocytes. The 
uninfected erythrocytes are subsequently labeled with Annexin V-FITC to check for PS 
exposure. The full set of conditions was carried out together during each experiment.  
(* represents p < 0.05, ** represent p < 0.01, ***represent p < 0.001; n=3)  
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3.3 Phagocytic Assay 
In order to study the relationship of PS externalisation, phagocytosis and subsequent cytokine 
release, a quick and simple way to measure phagocytic levels via flow cytometry was 
established using dihydroethidium, a viable DNA stain and CellTrace
TM
 Violet, a protein-
binding fluorophore.  
 
3.3.1 Dihydroethidium (DHE) staining and comparison with ethidium bromide  
To determine the optimal concentration for DHE-labeling of infected erythrocytes, 
concentrations of 5 µg/ml, 10 µg/ml, 25 µg/ml and 50 µg/ml were used to stain ring-staged 
Plasmodium falciparum culture of about 15% parasitemia. At 5 µg/ml DHE, the resolution 
between the parasite-infected population and the uninfected population was the most distinct, 
with the uninfected population having a relatively low background, as compared to 10 µg/ml, 
25 µg/ml and 50 µg/ml DHE (Figure 3.3). In addition, the parasitemia obtained via flow 
cytometry analysis at 5 µg DHE per milliliter was 14.42 % (Figure 3.3A) which corresponded 
to the microscopic count using the Giemsa smear (not shown). Comparing DHE with two 
other commonly used DNA stains (EB and Hoechst 33342), ring-staged parasite cultures were 
dually stained with either 5 µg/ml DHE and 1 µg/ml Hoechst 33342 or 10 µg/ml EB and 
1µg/ml Hoechst 33342. Hoechst 33342 is a cell membrane-permeable DNA stain which was 
used as the comparator between DHE and EB; both of which are derived from the same 
parent molecule, ethidine and fluoresce red when bound to DNA. At 5 µg/ml, approximately 
20% of the Hoechst-stained population (i.e. the infected erythrocytes) was co-stained with EB 
[Figure 3.4(1)A] whereas more than 90% erythrocytes in the Hoechst-stained population were 








Figure 3.3 Ring-staged 3D7 P. falciparum culture labeled with varying concentrations of 
dihydroethidium. Ring-staged cultures (at about 15 % parasitemia, 1% hematocrit) were 
labeled with (A) 5 µg/ml, (B) 10 µg/ml, (C) 25 µg/ml and (D) 50 µg/ml DHE for 20 min at 
37C and each was compared to an unstained blood control (gray shade histogram) using flow 
cytometry. Cultures labeled with 5 µg/ml DHE showed a clear resolution between infected 
and uninfected cells and the background from the uninfected cells was the lowest as 






Figure 3.4(1) Comparison between EB and DHE labelling of parasite DNA, using Hoechst 
33342 as a comparator. Ring-staged P. falciparum cultures at 20 % parasitemia, 1 % 
hematocrit were labeled with (A,) 10 µg/ml EB or (B) 5 µg/ml DHE, both of which were co-
stained with 1 µg/ml Hoechst 33342, for 20 min at 37C before analysis using flow 
cytometry. (A) Only about 20 % of Hoechst-labeled infected erythrocytes were stained with 
EB whereas (B) more than 90 % of Hoechst-labeled infected erythrocytes were stained with 








Figure 3.4(2) Confocal visualisation of EB and DHE labelling of parasite DNA, using 
Hoechst 33342 as a comparator. Ring-staged P. falciparum cultures at 20 % parasitemia, 1 % 
hematocrit were labeled with (C) 10 µg/ml EB or (D) 5 µg/ml DHE, both of which were co-
stained with 1 µg/ml Hoechst 33342, for 20 min at 37C before analysis using confocal 
imaging. (C) and (D) shows the corresponding confocal images to Figure 3.4(1A and B) 
which verify that DHE labelled a higher percentage of Hoechst-positive infected cells. Scale 




3.3.2 Ratio of THP-1 phagocytes to erythrocytes in phagocytic assay 
In the assay, THP-1, a human leukemia monocytic cell line, was used as the effector cells of 
phagocytosis. THP-1 cells were differentiated into macrophage-like cells using 10 ng/ml 
PMA. To confirm successful PMA differentiation, the expression levels of CD36 and CD68 
on the cell surface were measured. PMA-differentiated macrophages showed increased 
expression of both CD36 and CD68 compared to the undifferentiated cells (Figure 3.5). 
Increased auto-fluorescence of PMA-treated macrophages, shown in Figure 3.8(2) through 
the more diffused appearance of the general cell population in comparison to Figure 3.7(2), 
further validated the differentiation process (Daigneault et al., 2010).  
 
The effector to target (E:T) ratio in the phagocytic assay was optimised by incubating THP-1 
effectors with varying numbers of erythrocyte targets (uninfected and infected) for 4h at 5 % 
CO2 in 37C. There was an increase in erythrocyte uptake by the effectors incubated with 
higher proportions of targets (Figure 3.6). In Figure 3.6A, with monocytes as effectors, the 
level of phagocytosis of infected ring-staged cultures was higher than that of uninfected ones 
at E:T ratios of 1:100 (5.9 ± 0.6 %  with uRBC and 17.2 ± 2.9 % with ring culture; p < 0.005), 
1:200 (11.6 ± 1.2 % with uRBC and 31.0 ± 2.2 %; p < 0.001)and 1:260 (17.9 ± 1.6 % with 
uRBC and 37.9 ± 2.2 % with ring culture; p < 0.001). From Figure 3.6B, the level of 
phagocytosis of infected ring-staged cultures by macrophages was significantly higher than 
that of uninfected ones at E:T ratios of 1:50 (p < 0.05) and 1:100, 1:200 and 1:260 (all 3 with 
p < 0.001). At 1E:50T, the total uptake of fresh uRBC by THP-1 macrophages was 0.8 ± 
0.1% compared to the uptake of ring cultures, 4.2 ± 0.5 %. Uptake of fresh uRBC was 1.1 ± 
0.1 % compared to the uptake of ring cultures at 7.2 ± 0.8 % at 1E:100T; 1.8 ± 0.2 % 
compared to 11.8 ± 1.1% at 1E:200T and 2.2 ± 0.1 % compared to 13.0 ± 0.8 % at 1E:260T. 
An effector: target ratio of 1E:100T was selected for both monocytes and macrophages; the 
difference between the phagocytic levels of fresh uRBC and ring cultures were approximately 




Figure 3.5 Expression of surface markers on THP-1 cells before and after PMA 
differentiation. THP-1 monocytes (solid black line) and THP-1 macrophages differentiated 
with 10 ng/ml PMA (solid gray line) were incubated with (A) APC-Cy7 antihuman CD36 and 
(B) PE antihuman CD68 for 30min at 4C. This was done once and the differentiated 





Figure 3.6 Optimisation of effector (THP-1) to target (erythrocytes) ratio. The effectors used 
in these experiments were (A) THP-1 monocytes, (B) PMA-differentiated THP-1 
macrophages and the targets were pure uninfected erythrocytes (uRBC) or ring-staged 3D7 P. 
falciparum culture (ring culture) at 10 % parasitemia. The bar charts show the percentage of 
effectors that have engulfed at least one erythrocyte (uninfected or infected) at effector: target 
(E:T) ratios from 1:10 to 1:260 after 4h incubation at 37C, with pure effectors as the control. 
The experiments were done in duplicates at least 3 times with data expressed as mean ± SEM. 
Statistical analyses compared the number of effectors which had ingested erythrocytes from 
the uRBC culture with that from ring culture at the same E:T ratio.   




3.3.3 Validation of phagocytic assay with control conditions 
With the establishment of the phagocytic assay using a ratio of 1E:100T, several control 
experiments were carried out to validate the effectiveness of this method in reporting 
phagocytic activity of phagocytes. 
 
After incubation with phagocytes for 4h, there was a significant increase in the uptake of 
uninfected erythrocytes in schizont cultures compared to pure uninfected cultures. However, a 
similar comparison between uninfected erythrocytes in ring cultures and pure uninfected 
cultures was not significant in both monocytes and macrophages. With monocytes, uptake of 
pure uninfected erythrocytes was 3.5 ± 0.4 % compared to uninfected erythrocytes from 
schizont cultures [10.4 ± 1.6 %; p < 0.001; Figure 3.7(1)A]. Pure uninfected erythrocyte 
uptake by macrophages was 1.9 ± 0.4 % compared to uninfected erythrocytes from schizont 
cultures [5.6 ± 1.1 %; p < 0.001; Figure 3.8(1)A]. We also noticed an increase in macrophage 
phagocytosis of schizont-staged infected erythrocytes (4.4 ± 0.2 %) compared to ring-staged 
infected erythrocytes (1.6 ± 0.3 %) with p < 0.05 [Figure 3.8(1)B] but not in monocytes 
[Figure 3.7(1)B]. The uptake of ring- and schizont-infected erythrocytes in monocytes was 
similar to ring-infected erythrocytes uptake in macrophages.  
 
When the phagocytes were pretreated with cytochalasin D, a reversible actin polymerisation 
inhibitor (Schliwa, 1982), the level of phagocytosis was reduced in both infected erythrocytes 
and uRBCs in P. falciparum-infected cultures [Figure 3.7(1)A and B; Figure 3.8(1)A and B]. 
uRBC uptake in ring cultures by monocytes dropped from 6.2 ± 1.4% when untreated to 3.1 ± 
0.3 % with cytochalasin D treatment (p < 0.05). In schizont cultures, uRBC uptake levels 
were reduced from 10.4 ± 1.6 % to 4.6 ± 1.5 % (p < 0.001) after cytochalasin D treatment 
[Figure 3.7(1)A]. Looking at phagocytic levels in macrophages [Figure 3.8(1)A], uRBC 
uptake in ring cultures decreased from 3.3 ± 0.5 % to 0.3 ± 0.05 % (p < 0.01) and that in 
schizont cultures decreased from 5.6 ± 1.1 % to 0.4 ± 0.1 % (p < 0.001). In addition, 
phagocytosis of ring-staged infected erythrocytes uptake by monocytes was inhibited [from 
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1.1 ± 0.2 % to 0.06 ± 0.02 %; p <0.005; Figure 3.7(1)B]. Schizont-staged infected 
erythrocytes uptake by macrophages reduced from 4.4 ± 0.2 % to 0.2 ± 0.05 %, [p < 0.001; 
Figure 3.8(1)B].  
 
Phagocytic levels of P. falciparum-infected erythrocyte cultures increased significantly after 
opsonisation with heat-inactivated immune serum from a P. falciparum-positive patient [P. 
falciparum (+) serum]. With monocytes, ring-staged infected erythrocyte uptake increased 
from 1.1 ± 0.2 % to 9.5 ± 0.2 % (p < 0.001) and schizont-staged infected erythrocyte uptake 
from 1.1 ± 0.3 % to 12.1 ± 0.7 % (p < 0.001) when comparing samples opsonised by healthy 
human serum and P. falciparum (+) serum respectively [Figure 3.7(1)B]. In a similar 
comparison [Figure 3.8(1)B], phagocytosis by macrophages was also increased in ring-staged 
infected erythrocytes (from 1.5 ± 0.3 % to 3.2 ± 0.4 %; p < 0.05) and schizont-staged infected 
erythrocytes (from 4.6 ± 0.4 % to 8.0 ± 0.7 %, p < 0.001).  
 
This increase in phagocytosis after P. falciparum (+) serum opsonisation was observed not 
only in infected erythrocyte uptake but also in uRBC uptake. With THP-1 monocytes [Figure 
3.7(1)A], uRBC uptake in ring cultures increased from 8.1 ± 1.6 % to 24.4 ± 1.0 % (p < 
0.001) and uRBC uptake in schizont cultures from 15.2 ± 1.6 % to 42.9 ± 1.6 % (p < 0.001) 
when comparing again samples opsonised by healthy human serum and P. falciparum (+) 
serum. The same increase was seen in macrophages [Figure 3.8(1)A] with uRBC uptake in 
ring cultures increasing from 3.2 ± 0.4 % to 8.2 ± 0.1% (p < 0.001) and uRBC uptake in 
schizont cultures increasing from 5.6 ± 1.1 % to 9.3 ± 0.3 % (p < 0.001).   
 
It was also interesting to note that a large proportion of the increase in phagocytosis observed 
for P. falciparum-infected cultures in the various experiments was attributed to uptake of 
uRBCs and not just infected erythrocytes (Figure 3.7 and Figure 3.8), especially with THP-1 
monocytes. The THP-1 monocytes showed a high uRBC uptake from infected cultures 
compared to the THP-1 macrophages, particularly after P. falciparum (+) serum opsonisation. 
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Representative dot plots of the various conditions have been included to demonstrate the 
gating process of the phagocytes [Figure 3.7(2) and Figure 3.8(2)]. 
 
Samples were observed under confocal microscopy. Figure 3.9 shows the 3-dimensional z-
stack sections of phagocytes which have ingested either uninfected erythrocytes or infected 
erythrocytes from P. falciparum-infected cultures. FITC anti-human CD36 labeling the 
phagocyte surface demonstrated that the erythrocytes were indeed ingested by the phagocytes. 
As expected, the level of FITC fluorescence was lower in monocytes than in macrophages, 






Figure 3.7(1) Phagocytosis of pure uninfected erythrocytes (uRBC), 3D7 P. falciparum ring-
staged (ring culture) and schizont-staged cultures (schizont culture) at 10% parasitemia under 
various control conditions by THP-1 monocytes. In standard conditions, incubation of 
erythrocytes with monocytes was carried out for 4h at 37C with an E:T ratio of 1:100. To 
prevent phagocytosis, monocytes were pretreated with 5µM cytochalasin D for 1h before the 
phagocytic incubation of 4h at 37C. To increase phagocytosis, erythrocytes were opsonised 
with serum from a P. falciparum (+) patient at room temperature for 30 min before incubation 
with THP-1 monocytes. Incubation with healthy serum under the same conditions ensured 
that the increase in phagocytosis was not due to other factors in human serum. (A) THP-1 
monocytes that have engulfed at least one uRBC and (B) monocytes that have engulfed at 
least one infected erythrocyte. Data expressed as mean ± SEM. (B*vE*, p<0.05; a*vd*, 
p<0.01; A*vF*, C*vD*, F*vI*, G*vH*, b*vc*, f*vg*, p < 0.001; e*vh*, p = 0.063; A*vB*, p 






Figure 3.7(2) Representative dotplots of THP-1 monocytes after incubation with the 






Figure 3.8(1) Phagocytosis of fresh uninfected erythrocytes (uRBC), 3D7 P. falciparum ring-
staged (ring culture) and schizont-staged cultures (schizont culture) at 10 % parasitemia under 
various control conditions by THP-1 differentiated macrophages. In standard conditions, 
incubation of erythrocytes with macrophages was carried out for 4h at 37C with an E:T ratio 
of 1:100. To prevent phagocytosis, THP-1 macrophages were pretreated with 5 µM 
cytochalasin D for 1h before the phagocytic incubation of 4h at 37C. To increase 
phagocytosis, erythrocytes were opsonised with serum from a P. falciparum (+) patient at 
room temperature for 30 min before incubation with THP-1 macrophages. Incubation with 
healthy serum under the same conditions ensured that the increase in phagocytosis was not 
due to other factors in human serum. (A) THP-1 macrophages that have engulfed at least one 
uRBC and (B) THP-1 macrophages that have engulfed at least one infected erythrocyte. Data 
expressed as mean ± SEM. (bvc, p < 0.05; BvE, p < 0.01; AvF, CvD, FvI, GvH, evh, fvg, p < 





Figure 3.8(2) Representative dotplots of THP-1 macrophages after incubation with the 












Figure 3.9 Confocal visualization of engulfed erythrocytes in THP-1 monocytes and THP-1 
macrophages. Incubation of erythrocytes with phagocytes was carried out for 4h at 37C with 
an E:T ratio of 1:100 and the phagocytes are subsequently labeled with FITC anti-human 
CD36 before viewing under the confocal microscope. Z-stack sections of (A) a THP-1 
monocyte containing a CellTrace
TM 
Violet- labeled uninfected erythrocyte or an infected 
erythrocyte labeled with both CellTrace
TM 
Violet and DHE, (B) a THP-1 macrophage 
containing a CellTrace
TM 
Violet- labeled uninfected erythrocyte or an infected erythrocyte 
labeled with both CellTrace
TM 
Violet and DHE. Scale bar (in white): 5m 
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3.3.4 Phagocytic assay with test conditions 
As shown previously, there was a trend of increasing phagocytic levels of uninfected 
erythrocytes, under normal, untreated conditions, in the presence of P. falciparum and even 
further with later development (Figure 3.10A and Figure 3.11A); although the increase was 
not statistically significant. However, the increase in phagocytosis of schizont-staged infected 
erythrocytes was significantly higher than that of ring-staged infected erythrocytes by both 
THP-1 monocytes (p  < 0.001; Figure 3.10) and THP-1 macrophages (p < 0.001; Figure 3.11). 
 
To investigate the involvement of erythrocyte PS externalisation in phagocytic recognition, 
10 µg unlabelled Annexin V per 10 million erythrocytes was incubated with the erythrocytes 
(uninfected erythrocytes, ring-staged culture and schizont-staged cultures) for 30 minutes to 
block PS before the phagocytic incubation with the THP-1 phagocytes. This amount of 
Annexin V was previously optimised to block all the exposed PS on erythrocytes (data not 
shown). However, there is generally no significant change/decrease in phagocytic levels of 
both uninfected and infected erythrocytes by THP-1 monocytes (Figure 3.10) or THP-1 
macrophages (Figure 3.11), when compared with the corresponding untreated sample. 
Furthermore, the binding of Annexin V even increased phagocytosis of pure uninfected 
erythrocytes compared to that of the untreated pure uninfected erythrocytes in the THP-1 
monocytes (p < 0.05; Figure 3.10A) and THP-1 macrophages (p < 0.05; Figure 3.11A) and 
the phagocytosis of schizont-infected erythrocytes (p < 0.001; Figure 3.10B) in THP-1 
monocytes. 
 
The addition of cytochalasin D, as expected, significantly decreased the uptake of 
erythrocytes by phagocytes: in the THP-1 monocytes, the uptake of uninfected erythrocytes in 
the ring- and schizont-infected cultures was reduced from 5.6 ± 0.2 % to 1.9 ± 0.15 % (p < 
0.01) and 7.3 ± 0.7 % to 1.6 ± 0.2 % (p < 0.001) respectively (Figure 3.10A); the uptake of 
ring-infected erythrocytes dropped from 2.3 ± 0.5 % to 0.04  ± 0.03% (p < 0.001) and that of 
the schizont-infected erythrocytes from 5.2 ± 0.4% to 0.6 ± 0.3% (p < 0.001; Figure 3.10B); 
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in the macrophages, the uptake of uninfected erythrocytes in the schizont-infected culture was 
reduced from 4.1 ±1.6% to 0.7 ± 0.1% (p < 0.001; Figure 3.11A) and that in the schizont-
infected erythrocytes decreased from 7.9 ± 1.2% to 0.09 ± 0.04% (p < 0.001; Figure 3.11B). 
However, phagocytosis of uninfected erythrocytes by cytochalasin D-treated THP-1 
monocytes and THP-1 macrophages were not different from that in the untreated phagocytes. 
The phagocytic level of ring-infected erythrocytes also remained unchanged in the 
macrophages. While the uptake of uninfected erythrocytes from ring-stage cultures by 
cytochalasin D-treated macrophages was not significantly different from the untreated, there 
was a low p value of 0.08 (Figure 3.10 and Figure 3.11). 
 
The addition of LPS to the phagocytes activated them and increased phagocytosis. From 
Figure 3.10, the pretreatment of monocytes with LPS (with or without the addition of 
Annexin V to the erythrocytes) resulted in a significant increase in phagocytosis, with the 
exception of phagocytosis of the uninfected erythrocytes in the schizont-infected culture. 
Specifically, the uptake of uninfected erythrocytes increased from 3.1 ± 0.3% to 9.5 ± 1.9 % 
(p < 0.001) when the monocytes were pretreated with LPS, and to 12.7 ± 1.7% (p < 0.001) 
when Annexin V were added to the erythrocytes and LPS to the monocytes resepectively. 
Similarly, there was an increase in uninfected erythrocyte uptake in the ring-infected cultures 
both when treated with LPS (from 5.5 ± 0.3 % to 11.7 ± 1.8%; p < 0.001) or with LPS and 
Annexin V together (from 5.5 ± 0.3% to 9.1 ± 0.7%; p < 0.05). Ring-staged erythrocytes were 
phagocytosed more in the presence of LPS (from 2.3 ± 0.5% to 3.2 ± 1.1%; p < 0.01) and also 
LPS together with Annexin V (from 2.3 ± 0.5% to 3.7 ± 1.0%; p < 0.05). With schizont-
infected erythrocytes, the difference was more obvious; in LPS treatment, uptake increased 
from 5.2 ± 0.2% to 7.4 ± 0.1% (p < 0.001) and in LPS and Annexin V treatment, the increase 
was to 10.1 ± 0.8% (p < 0.001). A similar trend was observed with THP-1 macrophages 
(Figure 3.11). With LPS treatment, uptake of pure uninfected erythrocytes increased from 1.5 
± 0.5% to 4.4 ± 0.6% (p < 0.01); the increase was to 4.1 ± 1.0% (p < 0.05), with both LPS and 
Annexin V treatment. The uptake of uninfected erythrocytes from ring-infected cultures was 
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not different from the untreated control with LPS and Annexin V treatment (p = 0.096) but 
with LPS treatment alone, the uptake was increased from 2.7 ± 0.5% to 6.1 ± 0.9% (p < 
0.001). The uptake of ring-infected erythrocytes was the same in either treatment compared to 
the control but the uptake of schizont-infected erythrocytes increased in both LPS treated 
(from 7.9 ± 1.2% to 10.5 ± 2.0%; p < 0.01) and LPS with Annexin V treatment (from 7.9 ± 
1.2% to 10.6 ± 1.2%; p < 0.01). 
 
The combined treatment of LPS and cytochalasin D generally resulted in the inhibition of 
phagocytosis. Phagocytosis of uninfected erythrocytes in both ring-infected and schizont-
infected cultures by the THP-1 monocyteswere significantly reduced (p < 0.05) and the 
phagocytosis of the ring-infected erythrocytes and schizont-infected erythrocytes dropped 
from from 2.3 ± 0.5% to 0.02 ± 0.02%; p < 0.001 and from 5.2 ± 0.2% to 0.2 ± 0.01%; p < 
0.001 respectively, such that they were no longer different from each other (Figure 3.10). For 
the THP-1 macrophages, only phagocytosis of the uninfected erythrocytes in schizont-
infected culture was reduced from 4.1 ± 1.6% to 0.7 ± 0.3% (p < 0.001) and the uptake of 
schizonts was reduced from 7.9 ± 1.2% to 0.2 ± 0.2% (p < 0.001). However, phagocytosis of 
uninfected erythrocytes and erythrocytes of ring-infected cultures after treatment with both 






Figure 3.10 Phagocytosis of fresh uninfected erythrocytes (uRBC), 3D7 P. falciparum ring-
staged (ring culture) and schizont-staged cultures (schizont culture) at 10% parasitemia under 
different treatment conditions by THP-1 monocytes. In standard conditions (untreated), 
incubation of erythrocytes with monocytes was carried out for 4h at 37C with an E:T ratio of 
1:100. The treatment conditions included: 10 µg of unlabelled Annexin V (10 µg AnnV) per 
10 milliion cells added to the erythrocytes for 30 mins at 37C before incubating with THP-1 
monocytes, pretreatment of THP-1 monocytes with 5 µM cytochalasin D (cyto D) and 1 µg 
LPS per ml of culture for 1h before the phagocytic incubation of 4h at 37C. (A) THP-1 
monocytes that have engulfed at least one uRBC (A*vG*, A*vI*, B*vJ*, C*vF* with p < 
0.001; A*vC*, B*vE* with p<0.01; A*vD*, B*vH*, B*vK*, C*vL* with p < 0.05) and (B) 
monocytes that have engulfed at least one infected erythrocyte (a*vb*, c*vd*, g*vh*, i*vj*, 
a*ve*, a*vk*, b*vd*, b*vf*, b*vh*, b*vj*, b*vl* with p < 0.001; a*vi* with p < 0.01; a*vg* 
with p < 0.05). Data expressed as mean ± SEM with n = 3 separate experiments, each using 




Figure 3.11 Phagocytosis of fresh uninfected erythrocytes (uRBC), 3D7 P. falciparum ring-
staged (ring culture) and schizont-staged cultures (schizont culture) at 10% parasitemia under 
different treatment conditions by THP-1 macrophages. Under standard conditions (untreated), 
incubation of erythrocytes with macrophages was carried out for 4h at 37C with an E:T ratio 
of 1:100. The treatment conditions included: 10 µg of unlabelled Annexin V (10 µg AnnV) 
per 10 milliion cells added to the erythrocytes for 30 mins at 37C before incubating with 
THP-1 macrophages, pretreatment of THP-1 macrophages with 5 µM cytochalasin D (cyto D) 
and 1 µg LPS per ml of culture for 1h before the phagocytic incubation of 4h at 37C. (A) 
Macrophages that have engulfed at least one uRBC (BvJ, CvF, CvK with p < 0.001; AvI with 
p < 0.01; AvD, AvG with p < 0.05; BvE= 0.080; BvH=0.096) and (B) macrophages that have 
engulfed at least one infected erythrocyte (avb, cvd, fvg, hvi, ave, avj with p < 0.001; avg, avi 
with p < 0.01). Data expressed as mean ± SEM with n = 3 separate experiments, each using 
duplicate measurements.  
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3.4 Cytokine Production by THP-1 Phagocytes Following Phagocytosis of P. falciparum 
Cultures 
Cytokine production levels of the phagocytes (IL-6, TNF  and IL-10) were measured from 
culture supernatant collected 24 hours after phagocytosis of erythrocytes (either pure 
uninfected erythrocytes or those in P. falciparum cultures). Cytokine production by 
monocytes was generally very low and many samples were below the lower detection limits 
of the ELISA kits used. 
 
3.4.1 Cytokine production by THP-1 monocytes 
IL-6 production by THP-1 monocytes was undetectable for all treatment conditions except for 
the condition in which monocytes were pretreated with cytochalasin D and LPS before 
phagocytosis. Cytokine levels for monocytes incubated with ring- and schizont-infected 
cultures were above the lower detection limit of 32 pg/ml and significantly higher than all 
other conditions (p < 0.001; Figure 3.12A).  
 
Similarly, TNF  production was largely undetectable for the different treatment conditions 
except when the THP-1 monocytes were pretreated with cytochalasin D and LPS before 
phagocytosis and when THP-1 monocytes were incubated with schizont-infected cultures for 
the following treatments: Annexin V only, cytochalasin D only and LPS in combination with 
Annexin V. Treatment with cytochalasin D, particularly together with LPS, increase TNF  
production. In particular, TNF  production was significantly higher in cytochalasin D-
treated THP-1 monocytes incubated with schizont-infected cultures (p < 0.05) and in 
cytochalasin D with LPS- treated THP-1 monocytes, either alone or incubated with uninfected 
erythrocytes, ring-infected culture or schizont-infected cultures (all p < 0.001). In addition, 
phagocytosis of ring-infected cultures by THP-1 monocytes treated with cytochalasin D and 
LPS significantly reduced TNF  production compared to monocytes treated with 




For IL-10 production, only untreated THP-1 monocytes produced detectable levels after 





   
Figure 3.12 Concentration of cytokines produced by THP-1 monocytes after phagocytosis of 
either uninfected erythrocytes or 3D7 P. falciparum infected cultures (ring- or schizont-
staged) under various treatment conditions as stated previously. (A) IL-6, (B) TNF  and (C) 
IL-10 levels were measured using ELISA kits. Data shown is representative of 3 experiments, 
each with duplicates and expressed as mean ± SD. The untreated samples were used to 
indicate the baseline cytokine production of the phagocytes in comparison to the other 
treatment conditions. Variation within a treatment group was also investigated. Statistic 
analyses of the different associations were presented in the following tables. 
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Table 3.1A Statistical analysis of IL-6, TNF  and IL-10 production by THP-1 monocytes - 
comparisons within a treatment group where m represents THP-1 monocytes, U represents 
uninfected erythrocytes, R represents ring staged cultures and S represent schizont staged 
cultures. (n.s. - not statistically significant; * - p < 0.05; ** - p < 0.01; *** - p < 0.001) 
Within a 
treatment group 
m : (m+U) m : (m+R) m : (m+S) (m+U) : (m+R) (m+U) : (m+S) (m+R) : (m+S) 
       
IL-6       
       
Untreated n.s. n.s. n.s. n.s. n.s. n.s. 
10ug AnnV n.s. n.s. n.s. n.s. n.s. n.s. 
5uM cyto D n.s. n.s. n.s. n.s. n.s. n.s. 
AnnV +LPS n.s. n.s. n.s. n.s. n.s. n.s. 
1ug/ml LPS n.s. n.s. n.s. n.s. n.s. n.s. 
cyto D + LPS *** *** *** *** *** *** 
       
TNF        
       
Untreated n.s. n.s. n.s. n.s. n.s. n.s. 
10ug AnnV n.s. n.s. n.s. n.s. n.s. n.s. 
5uM cyto D n.s. n.s. n.s. n.s. * n.s. 
AnnV +LPS n.s. n.s. * n.s. * n.s. 
1ug/ml LPS n.s. n.s. n.s. n.s. n.s. n.s. 
cyto D + LPS n.s. ** n.s. n.s. n.s. n.s. 
       
IL-10       
       
Untreated n.s. n.s. n.s. n.s. n.s. n.s. 
10ug AnnV n.s. n.s. n.s. n.s. n.s. n.s. 
5uM cyto D n.s. n.s. n.s. n.s. n.s. n.s. 
AnnV +LPS n.s. n.s. n.s. n.s. n.s. n.s. 
1ug/ml LPS n.s. n.s. n.s. n.s. n.s. n.s. 
cyto D + LPS n.s. n.s. n.s. n.s. n.s. n.s. 






Table 3.1B Statistical analysis of IL-6, TNF  and IL-10 production by THP-1 monocytes - 
comparisons between treatment groups where m represents THP-1 monocytes, U represents 
uninfected erythrocytes, R represents ring staged cultures and S represent schizont staged 
cultures. (n.s., not statistically significant; * - p < 0.05; ** - p < 0.01; *** - p < 0.001) 
Between treatment groups m (m+U) (m+R) (m+S) 
     
IL-6     
     
control : 10ug AnnV n.s. n.s. n.s. n.s. 
control : 5uM cyto D n.s. n.s. n.s. n.s. 
control : AnnV +LPS n.s. n.s. n.s. n.s. 
control : 1ug/ml LPS n.s. n.s. n.s. n.s. 
control : cyto D + LPS n.s. *** *** *** 
      
TNF      
     
control : 10ug AnnV n.s. n.s. n.s. n.s. 
control : 5uM cyto D n.s. n.s. n.s. n.s. 
control : AnnV +LPS n.s. n.s. n.s. n.s. 
control : 1ug/ml LPS n.s. n.s. n.s. * 
control : cyto D + LPS *** *** *** *** 
     
IL-10     
     
control : 10ug AnnV n.s. (p=0.096) * n.s. n.s. 
control : 5uM cyto D n.s. *** n.s. n.s. 
control : AnnV +LPS n.s. n.s. (p=0.091) n.s. n.s. 
control : 1ug/ml LPS n.s. n.s. n.s. n.s. 





3.4.2 Cytokine production by THP-1 macrophages 
Looking at the different treatments (Figure 3.13A), the addition of unlabelled Annexin V to 
the erythrocytes compared to the untreated control increased the production of IL-6 by the 
THP-1 macrophages. For the THP-1 macrophages alone, IL-6 production increased from 320 
± 22 pg/ml to 1573 ± 37 pg/ml (p < 0.001). When THP-1 macrophages were incubated with 
uRBC, IL-6 production increased from 343 ± 8 pg/ml to 1621 ± 38 pg/ml (p < 0.001); with 
ring-infected cultures, IL-6 concentrations increased from 458 ± 29 pg/ml to 1591 ± 56 pg/ml 
(p < 0.001) and with schizont-infected culture, from 467 ± 51 pg/ml to 1697 ± 25 pg/ml (p < 
0.001). THP-1 macrophage incubation with cytochalasin D which inhibited phagocytosis of 
erythrocytes also inhibited the production of IL-6 when compared with the untreated control. 
With uninfected erythrocytes, IL-6 production was reduced to 143 ± 8 pg/ml (p < 0.001); with 
ring-infected cultures, 65 ± 1 pg/ml (p <  0.001) and with schizont-infected cultures, 126 ± 3 
pg/ml (p < 0.001). But for macrophages only, the addition of cytochalasin D did not change 
IL-6 concentrations compared to the untreated THP-1 macrophages. Cytochalasin D was able 
to inhibit IL-6 production even in the presence of LPS in all the samples (all p < 0.001). LPS 
alone augmented IL-6 production for all samples (p < 0.001) and with LPS together with 
Annexin V, IL-6 production was increased further (p < 0.001). The baseline IL-6 
concentration of THP-1 macrophages incubated only with LPS was 1400 ± 9 pg/ml and after 
phagocytosis of uninfected erythrocytes, the concentration dropped to 1012 ± 12 pg/ml (p < 
0.001). Similarly, phagocytosis of ring-infected cultures with LPS activation resulted in a 
decrease in IL-6 concentration (1185 ± 2 pg/ml; p < 0.001). But phagocytosis of schizont-
infected cultures did not change IL-6 levels (1487 ±51 pg/ml). With Annexin V and LPS 
treated, there was no significant changes in IL-6 productions (THP-1 macrophages alone) 
from 1611 ± 11 pg/ml to 1515 ± 11pg/ml with uninfected erythrocytes (p = 0.088) and to 
1713 ± 1 pg/ml with ring-infected cultures (p = 0.051). Conversely, after phagocytosis of 




TNF  production for the untreated THP-1 macrophages (Figure 3.13B) was similar, alone or 
after phagocytosis of erythrocytes (uninfected and infected). The addition of Annexin V 
increased TNF  concentration only for the sample with macrophages alone (from 270 ± 53 
pg/ml to 560 ± 122 pg/ml; p < 0.01) but there was no change after phagocytosis of 
erythrocytes (both uninfected and uninfected). Cytochalasin D, while inhibiting phagocytosis, 
did not manage to inhibit TNF  production. Instead, TNF  production increased 
significantly compared to the untreated control (for THP-1 macrophages only: from 270 ± 53 
pg/ml to 1011 ± 19 pg/ml (p < 0.001); for those with uninfected erythrocytes: from 259 ± 56 
pg/ml to 938 ± 16 pg/ml (p < 0.001); for those with ring-infected cultures, 379 ± 40 pg/ml to 
1077 ± 195 pg/ml (p < 0.001); for those with schizont-infected cultures, from 269 ± 7 pg/ml 
to 1098 ± 10 pg/ml (p < 0.001). The combination of cytochalasin D and LPS further 
augmented TNF  production (all p < 0.001), the concentrations all exceeding the upper 
detection limit of the ELISA kit. Treatment with LPS and LPS together with Annexin V did 
not change TNF concentration levels after phagocytosis of erythrocytes but with THP-1 
macrophages alone, LPS treatment caused an increase in TNF  levels (from 270 ± 53 pg/ml 
to 560 ± 42 pg/ml; p < 0.05) and LPS with cytochalasin D resulted in an increase from 270 ± 
53 pg/ml to 592 ± 142 pg/ml; p < 0.01. 
 
Similar to the THP-1 monocytes, IL-10 production for THP-1 macrophages were low (Figure 
3.13C), close to the lower detection limit. In the untreated samples, macrophages alone 
produced about 58 ± 7 pg/ml of IL-10 and for macrophages with uninfected erythrocytes, the 
IL-10 level was similar (59 ± 1 pg/ml). For THP-1 macrophages with ring-infected culture, 
IL-10 production was increased to 71 ± 2 pg/ml compared to macrophages alone (p < 0.05); 
for those with schizont-infected culture, it was further increased to 81 ± 5 pg/ml (p < 0.001). 
The other treatments resulted in a significant reduction in IL-10 production; statistical 












































Figure 3.13 Concentration of cytokines produced by THP-1 macrophages after phagocytosis 
of either uninfected erythrocytes or 3D7 P. falciparum infected cultures (ring- or schizont-
staged) under various treatment conditions as stated previously. (A) IL-6, (B) TNF  and (C) 
IL-10 levels were measured using ELISA kits. Data shown is representative of 3 experiments, 
each with duplicates and expressed as mean ± SD. The untreated samples were used to 
indicate the baseline cytokine production of the phagocytes in comparison to the other 
treatment conditions. Variation within a treatment group was also investigated. Statistic 
analyses of the different associations were presented in the following tables. 
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 Table 3.2A Statistical analysis of IL-6, TNF  and IL-10 production by THP-1 macrophages 
- comparisons within a treatment group where M represents THP-1 macrophages, U 
represents uninfected erythrocytes, R represents ring staged cultures and S represent schizont 
staged cultures. (n.s. - not statistically significant; * - p < 0.05; ** - p < 0.01; *** - p < 0.001) 
Within a 
treatment group 
M : (M+U) M : (M+R) M : (M+S) (M+U) : (M+R) (M+U) : (M+S) (M+R) : (M+S) 
       
IL-6       
       
Untreated n.s. ** ** * ** n.s. 
10ug AnnV n.s. n.s. ** n.s. n.s. * 
5uM cyto D * *** ** n.s. n.s. n.s. 
AnnV +LPS n.s.(p=0.088) n.s.(p=0.051) *** *** *** * 
1ug/ml LPS *** *** n.s. *** *** *** 
cyto D + LPS n.s.(p=0.086) n.s. *** n.s. *** *** 
       
TNF        
       
Untreated n.s. n.s. n.s. n.s. n.s. n.s. 
10ug AnnV n.s. n.s. * n.s. n.s. n.s. 
5uM cyto D n.s. n.s. n.s. n.s. n.s. n.s. 
AnnV +LPS n.s. n.s. * n.s. n.s. n.s. 
1ug/ml LPS n.s.(p=0.052) n.s. * n.s. n.s. n.s. 
cyto D + LPS ** * n.s. n.s. * * 
       
IL-10       
       
Untreated n.s. * *** * *** n.s. 
10ug AnnV n.s. n.s. ** n.s. n.s. (p=0.06) n.s. 
5uM cyto D n.s. n.s. n.s. n.s. n.s. n.s. 
AnnV +LPS n.s. n.s. ** n.s. n.s. (0.086) n.s. 
1ug/ml LPS n.s. n.s. n.s.(p=0.065) n.s. * n.s. 
cyto D + LPS n.s. n.s. n.s. n.s. n.s. n.s. 





Table 3.2B Statistical analysis of IL-6, TNF  and IL-10 production by THP-1 macrophages 
- comparisons between treatment groups where M represents THP-1 macrophages, U 
represents uninfected erythrocytes, R represents ring staged cultures and S represent schizont 
staged cultures. (n.s. - not statistically significant; * - p< 0.05; ** - p< 0.01; *** - p<0.001) 
Between treatment groups M (M+U) (M+R) (M+S) 
     
IL-6     
     
control : 10ug AnnV *** *** *** *** 
control : 5uM cyto D n.s. *** *** *** 
control : AnnV +LPS *** *** *** *** 
control : 1ug/ml LPS *** *** *** *** 
control : cyto D + LPS *** *** *** *** 
     
TNF      
     
control : 10ug AnnV ** n.s. n.s. n.s. 
control : 5uM cyto D *** *** *** *** 
control : AnnV +LPS ** n.s. n.s. n.s. 
control : 1ug/ml LPS * n.s. n.s. * 
control : cyto D + LPS *** *** *** *** 
     
IL-10     
     
control : 10ug AnnV *** ** *** *** 
control : 5uM cyto D *** *** *** *** 
control : AnnV +LPS *** ** *** *** 
control : 1ug/ml LPS ** ** *** *** 




















4.1 PS Externalisation in Infected and Uninfected Erythrocytes in Culture 
Results indicated that both infected and uninfected erythrocytes in P. falciparum cultures 
exposed PS molecules on their surface throughout the 48-hour erythrocytic developmental 
cycle.  However, the level of PS exposure, in reference to the infected erythrocytes, is in stark 
contrast with a previous study, also measuring PS externalisation in malaria-infected cultures 
(Eda and Sherman, 2002). While PS externalisation of uninfected erythrocytes in culture is 
agreed to be about 3 %, that in infected erythrocytes are much lower than the levels 
previously reported (49.9 % infected cells at early trophzoite stage and 68.4% at late 
trophozoite/schizont stage exposing PS). We noticed that in the study by Eda and Sherman 
(2002), propidium iodide was used to label the parasite DNA. Propidium iodide is a 
membrane-impermeant DNA-binding probe that is excluded from living cells. This could 
suggest that the cells used in that study had compromised plasma membranes which would 
result in Annexin V-FITC entering and labelling the cells from within. Also, while there was 
a trend of increase, we found no difference in PS externalization between erythrocytes of the 
various developmental stages. But PS externalization in the erythrocytes was distinctly higher 
than that in uninfected cells. 
 
Many studies have focused on phospholipid reorganisation in malaria-infected erythrocytes 
(Joshi and Gupta, 1988; Maguire et al., 1991; Becker et al., 2004; Lang et al., 2004, 2009; 
Pattanapanyasat et al., 2010); however, few have looked at that in uninfected erythrocytes 
(Gupta et al., 1982; Joshi et al., 1986). This is important as the majority of the erythrocyte 
population in blood stage parasite culture is uninfected and a small percentage of cells 
externalising PS represents a substantial number of cells. PS externalisation of uninfected 
erythrocytes could lead to increased phagocytosis by immune cells. Hence, we were 
interested to find out what caused PS flipping and the effects of phagocytosis on the immune 





4.2 PS Externalisation in Uninfected Erythrocytes Due to Spent Culture Media 
The effect of P. falciparum antigens in spent culture media on erythrocyte morphology and 
deformability had been previously studied (Read et al., 1990; Naumann et al., 1991) but 
similar studies on PS externalisation have not been done. To investigate the factor that caused 
PS externalisation, we used spent media from 3D7 P. falciparum cultures to induce PS 
exposure in pure uninfected erythrocytes. Previously, it was reported that hemin could induce 
PS externalisation and eryptosis in erythrocytes (Gatidis  et al., 2009). Hemin (Fe
3+
) is the 
oxidised form of heme (Fe
2+
) found in haemoglobin (Monti et al., 1999; Nagababu and 
Rifkind, 2004). Hence, it was speculated that haemazoin, the malarial pigment formed via 
polymerisation of toxic heme, and its breakdown products released into the spent media could 
be involved in inducing PS externalisation. This occurs possibly through increased oxidative 
stress (Kumar and Bandyopadhyay, 2005; Nuchsongsin et al., 2007). Albumin had previously 
been shown to inhibit catalatic and peroxidative activities of hemin (Grinberg et al., 1999); 
hence it was used to try to inhibit PS externalisation in the erythrocytes. However, 2% 
albumin had no effect on PS externalisation of erythrocytes. This observation requires more 
supporting evidence to eliminate heme in various forms as the inducer of PS exposure. From 
the results, the malarial factor that caused PS externalisation is observed to be particulate in 
nature with a size larger than 0.2 µm which could be removed by centrifugation and filtration. 
It is also heat-stable as heating did not inhibit PS exposure. Instead, it was increased. It is 
possible that heating caused the factor to change conformation or to break down into subunits 
which were more effective in inducing PS flipping. P. falciparum have been found to release 
soluble heat-stable and strain-specific antigens known as the S-antigens (Winchell et al., 
1985). While the identity of this malarial factor is still unknown, it is plausible that it may be 
stage- and strain-specific like the S-antigens. Future work still needs to be carried out to 






4.3 Establishment of Phagocytic Assay 
PS externalisation in erythrocytes during a P. falciparum infection can lead to PS recognition 
via PS receptors on phagocytes, resulting in phagocytosis. Phagocytosis of infected 
erythrocytes and subsequent parasite antigen presentation is a crucial step in initiating the 
adaptive immune response for the eradication of the malaria infection. Therefore, 
understanding how phagocytes interact with infected erythrocytes could be important in 
discovering ways to make the transition from innate to adaptive immunity more efficient. 
Also, since phagocytosis of self cells via PS interactions trigger the release of anti-
inflammatory mediators and the suppression of pro-inflammatory mediators, investigating the 
effect of phagocytosis of both uninfected and infected erythrocytes on cytokine release is 
important in understanding the parasite and the pathogenesis of malaria. In order to study 
phagocytosis in malaria, a new labelling method was created for rapid analysis via flow 
cytometry. DHE and CellTrace
TM 
Violet was used to label P. falciparum-infected cultures and 
visualize phagocytosis of erythrocytes, instead of ethidium bromide (EB) and FITC, as 
previously described (Tippett et al., 2007).  
 
The advantage of this method is that it enables phagocytic levels of P. falciparum cultures at 
different developmental stages, including the early ring stages, to be assayed. To date, few 
studies have focused on ring-staged infected erythrocytes, as opposed to the later more 
antigenic trophozoite and schizont stages. But knowing that the spleen is a major organ 
involved in the clearance of infected erythrocytes and that ring-staged infected erythrocytes 
are the main form in circulation which passes through the spleen periodically, we are 
interested in studying phagocytosis of the early ring-staged infected erythrocytes, along with 
the later stages. Another advantage of this method is that it allows both phagocytosis of 
uninfected and infected erythrocytes to be studied concurrently, without the need to separate 





4.3.1 Parasite DNA and erythrocyte labelling 
Three different DNA binding probes (DHE, EB and Hoechst) were compared for this assay. 
DHE, a neutral molecule, is the chemically reduced form of EB. It is able to penetrate the 
intact membranes of host erythrocytes, even in the early ring stages, before it is oxidized to 
form positively-charged ethidium which intercalates with DNA in the parasite nucleus 
(Bucana et al., 1990). EB, however, is directly ionized into ethidium and bromide ions in 
solution. These charged particles are typically unable to pass through the membrane but 
infected erythrocytes become more permeable in the course of Plasmodium development, 
with a marked increase in permeability during the trophozoite stage. This is due to the 
formation of new permeability pathways (NPPs) in the host cell membrane and it coincides 
with the enhanced metabolic activity of the parasites at this stage (Ginsburg et al., 1985; 
Staines et al., 2000). Only after the parasite develops and creates NPPs in the host erythrocyte 
membrane during the later trophozoite/schizont stages, EB is able to penetrate the cell 
membrane to bind to parasite DNA. Hoechst 33342 is another frequently used DNA stain and 
like DHE, it can label infected erythrocytes of different stages as well. But Hoechst has poor 
cellular retention and diffused out of the infected erythrocytes to stain phagocyte nuclei as 
well. This made it difficult to differentiate by flow cytometry, whether an infected erythrocyte 
had been ingested (data not shown). In addition, the excitation and emission wavelengths of 
Hoechst 33342 are approximately 350/461nm which generally requires a UV laser to be 
detected by flow cytometry. To date, this laser is only available in large and sophisticated 
instruments. Hence, DHE, which can be used with cheaper and commonly available 488 nm 
laser, is the ideal stain, particularly if labelling ring staged-infected erythrocytes with 
relatively unmodified cell membranes. 
 
To label the erythrocyte cytoplasm, we have employed CellTrace
TM 
Violet which is excited at 
405nm and emits at 450nm. The emission spectra of CellTrace
TM 
Violet and DHE do not 




4.3.2 Validation of phagocytic assay 
We validated this method by successfully inhibiting phagocytosis with an actin 
polymerisation inhibitor, cytochalasin D and increasing phagocytosis via incubation with P. 
falciparum immune serum. Notably, apart from phagocytosis of infected erythrocytes, the 
results also showed high levels of phagocytosis of uninfected erythrocytes in parasite cultures. 
With the formation of NPPs and hence increased permeability in erythrocyte membrane, there 
could be release of parasite antigens such as ring surface protein 2 (RSP2) into the 
surroundings which might bind directly to neighbouring uninfected cells (Taraschi, 1999; 
Layez et al., 2005). Uninfected erythrocytes present in the cultures of P. falciparum have also 
been shown to display reduced deformability (Dondorp et al., 1999) and accelerated 
senescence in comparison to control cells of the same age (Omodeo-Salè et al., 2003). In 
combination with the observation that uninfected erythrocytes in culture or in spent culture 
media exhibited increased PS exposure on their cell surfaces, this could result in an increase 
in detection by phagocytes and thus suggest reasons for the high levels of uninfected 
erythrocyte phagocytosis. These findings concur with studies demonstrating that majority of 
erythrocytes lost in falciparum malaria patients are uninfected (Salmon et al., 1997; Jakeman 
et al., 1999; Price et al., 2001; Ekvall, 2003; Lamikanra et al., 2007; Totino et al., 2010; 
Buffet et al., 2011) and explains why the extent of anaemia does not always correlate with 
parasite density. Indeed, premature recognition and elimination of uninfected erythrocytes 
due to the malarial infection would lead to an accelerated development of anaemia.  
 
For the infected erythrocytes, we saw increased uptake of infected erythrocytes as they 
developed from rings to schizonts. As the parasite develops, parasite antigens are inserted into 
the host erythrocyte membranes, particularly during the later stages of development. These 
neoantigens are easily recognised by phagocytes (Hommel and Semoff, 1988), hence 
explaining this observation. After the addition of P. falciparum immune serum for 
opsonisation, there was a significant increase in phagocytic levels of the P. falciparum-
infected infected erythrocytes due to increased efficiency of Fc receptor (FcR)-mediated 
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phagocytosis. This was not observed when non-immune control serum was added instead, 
validating the power of this assay to detect changes in phagocytic levels due to different 
treatments. 
 
While other studies have shown that macrophages generally display greater phagocytic ability 
than monocytes (Van Furth et al., 1972; Newman et al., 1982), our assay showed a different 
result. The trend held where macrophage phagocytic levels of schizont-staged erythrocytes 
(untreated or incubated with nonimmune control serum) were higher than that of monocytes, 
possibly due to an increase in surface receptors such as CD36 (McGilvray et al., 2000). But it 
is presently unclear why monocyte phagocytic levels of uninfected erythrocytes in cultures 
were elevated, particularly after P. falciparum immune serum opsonization. More studies 
investigating this phenomenon are warranted.  
 
4.4 Phagocytic Assay with the Addition of Annexin V 
Using this method, we tested the effect of blocking externalised PS with Annexin V on 
phagocytosis, to investigate the role of PS externalisation in malaria pathogenesis. We 
expected to see a decrease in phagocytosis of erythrocytes in accordance to what was reported 
in other studies (Krahling et al., 1999; Callahan et al., 2000; Stach et al., 2000). However, this 
was not observed and in some case, phagocytosis was even enhanced.  
 
Annexin V binding to PS is a Ca
2+
- dependent process. It was noted that the binding was 
unstable as after Annexin V incubation, washing the erythrocytes with Annexin V binding 
buffer resulted in the dissociation of Annexin V. This was verified via the addition of FITC-
Annexin V. With washing, FITC-Annexin V binding was detectable; in contrast, little or no 
FITC-Annexin V bound in the absence of the wash steps (data not shown). Unstable binding 
and low levels of PS externalisation in erythrocytes from P. falciparum cultures could explain 
the lack of phagocytic inhibition. We tried to set up a positive control by treating the 
erythrocytes with ionomycin, a Ca ionophore, to artificially increase PS externalisation; 
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however, ionomycin treatment resulted in high levels of erythrocyte lysis which prevented 
meaningful comparisons (data not shown). It is possible that PS is not involved in phagocytic 
clearance in the case of malaria. After the discovery that a malaria infection could result in 
increased apoptosis and hence PS externalisation in host cells, many have attributed increased 
phagocytic clearance to PS recognition by monocytes/macrophages (Ekvall, 2003; Lang et al., 
2004; Zwaal et al., 2005; Föller et al., 2009; Totino et al., 2010; Matsuzaki-Moriya et al., 
2011). However, studies which used PS liposomes to block  phagocytosis have not been 
completely successful (Turrini et al., 1992; Serghides and Kain, 2001) for both ring-stage and 
trophozoite-staged cultures. Also, of note, while Annexin V has been used to block 
phagocytosis of apoptotic cells in many studies, it has not been reported in malaria-infected 
erythrocytes. It is possible that the increase in phagocytosis is due to malarial antigens on the 
surface of infected cells or those that have been released and adhere to the surfaces of 
uninfected erythrocytes. Steric hindrance due to these antigens could obscure the involvement 
of externalised PS. A third possibility is that while PS is involved in phagocytosis, 
phagocytosis of erythrocytes can occur through both pathways: PS-mediated or pathogen-
association molecular patterns (malarial antigens) recognition. Hence, the blocking of 
externalised PS via Annexin V did not have a noticeable effect on phagocytic levels. More 
needs to be done in confirming these speculations. 
 
While the presence of LPS activated the monocytes/macrophages and generally increased 
phagocytosis, this was not seen in all the samples. Since the increase was seen more 
significantly in the THP-1 monocytes, it is likely that the THP-1 macrophages were already 
near its maximal activation and could not be activated further. Once again, Annexin V did not 
have an effect in inhibiting phagocytosis, even in combination with LPS.  
 
4.5 Cytokine Production in Both THP-1 Monocytes and Macrophages 
Cytokine levels for the THP-1 monocytes were generally very low and mostly below the 
detection level of the ELISA kits used. Previously, it was found that THP-1 monocytes were 
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rarely used for detecting cytokines without differentiation by either PMA or 1, 25-
dihydroxyvitamin D3 whereas differentiated THP-1 macrophages were noted to be useful in 
studying immunity to Plasmodium (Kumaratilake et al., 1997). So in the discussion, we will 
focus on cytokine production by the differentiated THP-1 macrophages.  
 
The outcome of malaria depends on the balance between pro-inflammatory and anti-
inflammatory mediators. With high pro-inflammatory signals, parasite clearance happens 
quickly but it may results in systemic inflammation which is harmful to the host (Clark et al., 
2006, 2008). On the other hand, high levels of anti-inflammatory mediators can be beneficial 
in lowering inflammation and its resulting damage to the body but at the same time, that 
would suppress host cellular immune responses, allowing parasite perpetuation (Peyron et al., 
1994; Taylor-Robinson and Smith, 1999; Niikura et al., 2011). Hence, while secretion of pro-
inflammatory cytokines is important for parasite clearance and infection resolution, these 
cytokines need to be down-regulated at appropriate times in order to avoid immunopathology. 
Also, the baseline production of cytokines may vary in individuals due to genetic 
polymorphism in these cytokines. In this study, we employed the use of THP-1 cell line 
which neglects the genetic variations present in a population.  
 
4.5.1 IL-6 
IL-6 (22 to 27 kDa) is a pleiotropic cytokine, mainly produced by monocytes and 
lymphocytes but also by many other cells such as fibroblasts, adipocytes, endothelial cells and 
bone marrow stroma cells. IL-6 has both pro-inflammatory and anti-inflammatory properties. 
It has been found to be induced by pro-inflammatory cytokines, IL-1 and TNF , with which 
it shares overlapping functions. But IL-6 also regulates IL-1 and TNF  production through 
the induction of IL-1 and TNF  antagonists and blocks pro-inflammatory cytokine 
expression. IL-6 is known to result in B cell differentiation and activation of T cells, 
promoting the development of acquired immunity(Akira et al., 1990; Hirano et al., 1990; 
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Xing et al., 1998; Jones, 2005; Stenvinkel et al., 2005). This is particularly of interest as 
mechanisms of immunity against malaria is poorly known and studying IL-6 and its 
production could help further knowledge in developing protective antibodies against malaria. 
 
In malaria, IL-6 was found to be both detrimental to the development of the disease but yet 
also helpful in its control. High IL-6 levels were associated with hyperparasitemia, jaundice, 
shock and fatal outcomes and it was elevated in cerebral malaria patients and those with renal 
failure (Jakobsen et al., 1994; Thuma et al., 1996; Wenisch et al., 1999; Angulo and Fresno, 
2002). However, IL-6 was also found to be involved in the inhibition of malaria hepatic 
stages (Nussler et al., 1991; Pied et al., 1991) and that the administration of recombinant IL-6 
to infected mice could suppress secondary parasitemia through the increased levels of 
protective antibodies (Akanmori et al., 1996).  
  
In our study, the addition of Annexin V caused an approximately 4-fold increase in IL-6 
production, this is either through direct stimulation of the macrophages or the inhibition of 
erythrocyte uptake via the PS interaction pathway which leads to upregulation of 
inflammation due to the increased immunogenicity of the cells (Stach et al., 2000). But 
further investigations are required to determine the correct explanation. However, if the latter 
is true, it suggests that the hypothesis that phagocytosis occurs through two pathways (PS-
mediated or malarial antigen recognition) could be right. Pretreatment of macrophages with 
LPS also lead to an increase in IL-6 but phagocytosis of uninfected erythrocytes and ring-
staged cultures managed to reduce IL-6 production. This strengthens the hypothesis of two 
phagocytic pathways as phagocytosis of uninfected erythtocytes and early stage infected 
culture are able to reduce inflammation levels. The induction of IL-6 via Annexin V can be 
exploited to investigate if the upregulation of IL-6 at different stages of the malarial infection 





4.5.2 TNF  
TNF  (17kDa) is an autocrine pro-inflammatory cytokine produced mainly by activated 
macrophages and also by other cell types such as neutrophils, mast cells and T lymphocytes. 
It is one of the central cytokines in inducing inflammation as it stimulates the production of 
other inflammatory cytokines and chemokines through the NF-B and the MAPK pathways 
and recruits activated leukocytes to the infection site (Beutler and Cerami, 1989; Stenvinkel et 
al., 2005; Levine, 2006; Chu, 2013).  
 
TNF  is produced early in the malarial infection and works to control parasitemia via cell-
mediated pathways. The stimulation of TNF  in the erythrocytic stage is triggered by 
schizont rupture and the release of parasite antigens into the bloodstream (Jacobs et al., 1996; 
Richards, 1997). Like IL-6, TNF  has both protective and harmful effects in malaria. 
Elevated TNF  levels are associated with parasite clearance and control of parasitemia in the 
initial infection and the absence of TNF  during malaria infection was shown to lead to 
increased parasitemia. But excessive TNF  production leads to immunopathology and 
contribute to the disease state (Kern et al., 1989; Kremsner et al., 1995; Jacobs et al., 1996; 
Richards, 1997; Angulo and Fresno, 2002; Hassan Da et al., 2012). 
 
From our results, treatment by Annexin V and LPS did not change the levels of TNF 
production which is surprisingly as LPS has been reported repeatedly to be a strong inducer of 
TNF . A possible explanation could be that TNF  has a short half-life (Oliver et al., 1993; 
Kishore et al., 2004) and it is produced rapidly at the initial phase of the stimulus, hence the 
peak of TNF  production had past after 24h and some may have been degraded. While TNF 
 measured in the serum of humans was reported to be generally correlated with IL-6 levels 
in malaria (Mshana et al., 1991; Clark et al., 1992; Baker et al., 2008; Robinson et al., 2009), 
this was not observed in our experiments. Such an observation supports a previous study 
which reported that TNF  and IL-6 secretion, in response to malaria antigens, were 
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stimulated independently with different kinetics (Prada et al., 1993). Another unexpected 
observation was the augmentation of TNF  secretion when exposed to cytochalasin D. The 
explanation for this is currently not known; however, the contamination of endotoxins from 
the cytochalsin D preparation may lead to such an observation. 
  
4.5.3 IL-10 
IL-10 (18 kDa) is produced mainly by monocytes and lymphocytes. It is considered one of 
the more important anti-inflammatory cytokines involved in immune regulation. Its induction 
is typically delayed and follows the release of pro-inflammatory cytokines. IL-10 works to 
regulate and suppress inflammatory cytokines such as IL-6 and TNF  (Fiorentino et al., 
1991; Malefyt et al., 1991; Peyron et al., 1994; Ho et al., 1998; Stenvinkel et al., 2005). In 
murine malarial models, it has been found that high levels of IL-10 is associated with high 
parasitemia, severe anemia and death, possibly due to immune suppression (Kobayashi et al., 
1996; Couper et al., 2008). However, the absence of IL-10, either through anti IL-10 or anti-
IL10R antibodies administration or infection in IL-10 knockout mice, led to the development 
of malaria complications (Kobayashi et al., 2000; Sanni et al., 2004; Niikura et al., 2010). 
This once again demonstrates the role of the delicate balance between different cytokines in 
the progression of disease.  
 
In the untreated samples, phagocytosis of infected cultures resulted in an increase in IL-10 
levels. This increase in IL-10 is not due to phagocytosis of apoptotic cells as it was not seen in 
the macrophages incubated with uninfected erythrocytes. Since IL-10 is typically produced in 
response to pro-inflammatory mediators, parasite-induced inflammation could have resulted 
in this increase. After Annexin V treatment, we saw low levels of IL-10 production, 
suggesting that Annexin V had increased the immunogenicity of the cells, as proposed when 
observing IL-6 production in similarly treated cells. The inhibition of phagocytosis also 
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suppressed the production of IL-10 which is consistent with the knowledge that IL-10 is not 
produced in the absence of inflammatory stimulation.  
It is vital to remember that cytokines function in relation to each other in the host system and 
their overall balance determines the course of the immune progression. It has been found that 
while individual cytokine concentrations are important, the analysis of the different cytokine 
ratios also act as indicators of the outcome of the disease. A low IL-10:TNF ratio is associated 
with malarial anaemia (Othoro et al., 1999; May et al., 2000; Nussenblatt et al., 2001; Niikura 
et al., 2011) and low IL-10:IL-6 ratios have been associated to fatal malaria (Day et al., 1999; 
Lyke et al., 2004). However, it is difficult to draw accurate conclusions about the cytokine 


















FUTURE WORK AND CONCLUSIONS  
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5.1 Future work 
1) In investigating the factor involved in PS, we managed to narrow the search to a heat 
stable particle which is larger than 0.2 µm in size. In order to further explore its 
identity, experiments involving enzymatic digestion (using broad spectrum enzymes) 
and possibly mass spectrometry would be essential.  
 
2) The addition of Annexin V to erythrocytes (infected or otherwise) did not manage to 
block phagocyosis by THP-1 phagocytes. Several possibilities were suggested: 
detachment of Annexin V from bound erythrocytes, PS interactions not being 
involved in erythrocyte clearance and multiple pathways of phagocytosis obscuring 
the involvement of PS. To clarify these doubts, other inhibitors of phagocytosis can 
be used. It has been found that macrophages can use different receptors for the 
clearance of apoptotic cells, a synthetic peptide RGDS can inhibit phagocytosis via 
the vitronectin receptor and N-acetylglucosamine can block lectin receptors (Fadok et 
al., 1998). Trypsin treatment can be used to remove malarial surface antigens from 
erythrocytes before treatment and phagocytosis to test the hypothesis that these 
antigens obscure PS involvement in phagocytosis (Berendt et al., 1990; Fernandez et 
al., 1999; Ayi et al., 2005; Winter et al., 2005). 
 
3) Finally, in exploring the cytokine production due to phagocytosis of erythrocytes 
(uninfected or infected with parasites of different development stages), the single 
timepoint of 24h was insufficient as the cytokines are induced at different stages 
(with TNF  being induced at the initial stage). Hence, it is necessary to collect the 
supernatant for cytokine analysis at multiple timepoints. The following timepoints are 
suggested: 0, 6 12, 24 36 and 48h.  Also, the overall effects of cytokines on the 
immune system and the host depend largely on the amounts produced in relation to 
each other. To obtain a more accurate picture, more cytokines should be assayed. 
These cytokines (IL-1β, IL-12, TGF-β and IFN-γ) have also been implicated in 
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malaria immunity (Richards, 1997; Day et al., 1999; Dodoo et al., 2002; Wroczyńska 





In summary, our findings on PS externalisation, its relationship to phagocytosis and the 
effects on cytokine productions are outlined as follows: 
 
1) It was found that both infected and uninfected erythrocytes expose PS throughout the 
48-hour erythrocytic developmental cycle of P. falciparum, at levels between 1.7% 
to 3.2% for the uninfected cells and 2.7% to 5.9% for the infected cells in culture. 
2) The factor that caused this phenomenon of PS externalisation is released into the 
culture media by P. falciparum parasites. 
3) The malarial factor which induced PS externalisation has a size of more than 0.2um 
and heating enhances its ability to induce PS externalisation.  
4) A new method to assay for phagocytosis using flow cytometry was established, using 
DHE to label parasite DNA and CellTrace
TM
 Violet to label the erythrocyte 
cytoplasm, allowing different populations and parasite stages to be analysed easily 
(Chan et al., 2012). 
5) We demonstrated that both infected and uninfected erythrocytes in P. falciparum 
cultures were phagocytosed by both THP-1 monocytes and differentiated 
macrophages and as expected, the uptake of schizont-infected erythrocytes were 
higher than that of ring-infected erythrocytes. 
6) However, unlabelled Annexin V which binds to externalised PS did not manage to 
inhibit phagocytosis of erythrocytes. 
7) Cytokine production in THP-1 monocytes after phagocytosis of infected cultures was 
low and hence, not suitable for investigating cytokine profiles. 
8) The addition of unlabelled Annexin V resulted in an increase in IL-6 production and 
a drop in IL-10 production in THP-1 differentiated macrophages, which may indicate 
an increase in pro-inflammatory signals. 
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9) The role of PS in the phagocytosis of P. falciparum erythrocyte cultures and the 
subsequent cytokine production still remains unclear; however, the presence of 
apoptotic mimicry in P. falciparum cannot be ruled out.  
10) Further investigations involving various phagocytic inhibitors and the measurement 
of other different cytokines are required to elucidate the role of PS. This is important 






Figure 5.1 A summary model of hypothesis, findings and future directions. Infection of 
erythrocytes by Plasmodium falciparum results in the release of a heat stable, particulate 
factor which induces PS externalisation in both infected and uninfected erythrocytes. This 
could be a form of parasite-induced apoptotic mimicry. The identity of the factor is still 
unknown and can be clarified using enzymatic digestion and/or mass spectrometry. 
Macrophages/monocytes possess receptors that can recognise exposed PS and ingest the 
erythrocytes. PS-mediated phagocytosis leads to the down regulation of inflammation via the 
suppression of pro-inflammatory mediators and the increased expression of anti-inflammatory 
mediators. Overall, Annexin V (a PS binding protein) did not inhibit erythrophagocytosis but 
caused increased inflammation. It is necessary to investigate the pathway of 
erythrophagocytic uptake using other possible inhibitors such as RGDS peptides. The 
production for other cytokines can be measured at different timepoints for a clearer view of 
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Figure S1 Giemsa stain of ring-staged 3D7 Plasmodium falciparum cultures with a 








Figure S2 Expression of surface markers on THP-1 cells before and after PMA 
differentiation. THP-1 monocytes (solid black line) and THP-1 macrophages differentiated 
with 10 ng/ml PMA (solid gray line) were incubated with A) APC-Cy7 antihuman CD36 and 
B) PE antihuman CD68 for 30 min at 4C. The differentiated macrophages showed an up-










Figure S3 Forward and side scatter plot of 3D7 Plasmodium falciparum cultures with the 
R18 gating used to analyze the erythrocyte population for determining optimal DHE 
concentration. 
 
